Edgar Filing: PAINCARE HOLDINGS INC

Prospectus Supplement

Filed pursuant to Rule 424(b)(3)

Registration Statement File No. 333-135883

PROSPECTUS SUPPLEMENT DATED AUGUST 29, 2007

PROSPECTUS DATED MAY 8, 2007

PAINCARE HOLDINGS, INC.

This prospectus supplement should be read in conjunction with our prospectus dated May 8, 2007 and in particular “Risk Factors” beginning on page 4 of the prospectus.

This prospectus supplement includes the attached Quarterly Report on Form 10-Q of PainCare Holdings, Inc., filed with the Securities and Exchange Commission on August 28, 2007.

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the Quarterly Period Ended June 30, 2007

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 1-14160

PAINCARE HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Florida

06-1110906

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification No.)

1030 N. Orange Avenue, Suite 105, Orlando, Florida 32801

(Address of Principal Executive Offices)

(407) 367-0944

(Registrant’s Telephone Number)

Indicate by check mark whether the registrant (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large Accelerated Filer ¨ Accelerated Filer x Non-Accelerated Filer ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ¨ Yes x No

As of August 23, 2007 there were 67,532,050 outstanding shares of the Registrant’s common stock, $0.0001 par value.

PAINCARE HOLDINGS, INC.

INDEX

Table of Contents to Form 10-Q for the Six Months Ended June 30, 2007


		Page
PART I	FINANCIAL INFORMATION

Item 1.	Financial Statements	1
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	26
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	37
Item 4.	Controls and Procedures	38

PART II	OTHER INFORMATION

Item 1.	Legal Proceedings	44
Item 1A	Risk Factors	45
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	45
Item 3.	Defaults Upon Senior Securities	45
Item 4.	Submission of Matters to a Vote of Security Holders	45
Item 5.	Other Information	45
Item 6.	Exhibits	46
	Signatures	47

PAINCARE HOLDINGS, INC.

Consolidated Balance Sheets

As of June 30, 2007 and December 31, 2006


	June 30, 2007			December 31, 2006
	(unaudited)
Assets
Current assets:
Cash and cash equivalents	$	931,569		$	2,695,460
Accounts receivable, less allowance for doubtful accounts of $1,148,006 and $1,104,834		7,940,064			8,650,466
Deposits and prepaid expenses		319,551			649,668
Note receivable		636,413			500,000
Current deferred tax asset		3,348,371			1,921,825
Income tax receivable and deferred tax asset		5,580,836			4,135,376
Current assets of discontinued operations		6,650,142			12,567,030

Total current assets		25,406,946			31,119,825
Property and equipment, net		8,480,135			8,994,837
Goodwill, net		42,161,346			56,455,055
Other assets		3,295,967			3,824,044
Non-current assets of discontinued operations		11,557,216			62,983,972

Total assets	$	90,901,610		$	163,377,733


Liabilities and Stockholders’ Equity

Liabilities:
Accounts payable and accrued expenses	$	4,907,757		$	4,295,402
Accrued interest		3,037,915			781,971
Acquisition consideration payable		811,998			4,026,209
Current portion of notes payable		22,436,759			34,053,378
Current portion of convertible debentures		12,839,354			12,415,480
Derivative liabilities		600,000			600,000
Current portion of capital lease obligations		1,196,410			1,383,790
Current liabilities of discontinued operations		1,766,500			2,042,215

Total current liabilities		47,596,693			59,598,445
Capital lease obligations, less current portion		1,399,172			1,717,138
Non-current deferred tax liability		3,348,371			2,254,403
Non-current liabilities of discontinued operations		—			264,968

Total liabilities		52,344,236			63,834,954

Minority interests related to discontinued operations		2,904,605			2,191,797
Stockholders’ equity:
Common stock, $.0001 par value. Authorized 200,000,000 shares; issued and outstanding 67,532,050 and 66,292,721 shares, respectively		6,753			6,629
Preferred stock, $.0001 par value. Authorized 10,000,000 shares; issued and outstanding -0- shares
Additional paid in capital		143,410,198			142,763,156
Accumulated deficit		(107,860,529	)		(45,465,595	)
Accumulated other comprehensive income		96,347			46,792

Total stockholders’ equity		35,652,769			97,350,982

Total liabilities and stockholders’ equity	$	90,901,610		$	163,377,733

See accompanying notes to consolidated financial statements.

PAINCARE HOLDINGS, INC.

Consolidated Statements of Operations

For the Three and Six Months Ended June 30, 2007 and 2006 (unaudited)


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2007			2006			2007			2006
				(As restated)						(As restated)
Revenues:
Pain management	$	6,111,888		$	6,568,065		$	12,276,948		$	12,339,476
Surgeries		859,172			1,604,047			2,201,365			3,485,077
Ancillary services		2,605,306			2,669,732			5,466,076			7,163,899

Total revenues		9,576,366			10,841,844			19,944,389			22,988,452
Cost of revenues		5,208,931			3,000,576			8,710,749			5,683,077

Gross profit		4,367,435			7,841,268			11,233,640			17,305,375
General and administrative expense		8,201,889			10,477,491			17,945,617			9,685,231
Impairment		15,225,074			—			15,225,074			—
Amortization expense		191,017			564,045			222,600			1,006,957
Depreciation expense		473,911			401,812			901,478			838,405

Operating income (loss)		(19,724,456	)		(3,602,080	)		(23,061,129	)		5,774,782
Interest income (expense)		(1,539,452	)		(1,424,349	)		(3,277,368	)		(2,038,000	)
Derivative benefit (expense)		—			98,396			—			10,492,951
Other income (expense)		(35,464	)		313,840			(10,215	)		440,421

Income (loss) from continuing operations before income taxes		(21,299,372	)		(4,614,193	)		(26,348,712	)		14,670,154
Benefit (provision) for income taxes		146,655			1,466,685			1,886,453			(1,927,304	)

Income (loss) from continuing operations		(21,152,717	)		(3,147,508	)		(24,462,259	)		12,742,850

Discontinued operations:
Income (loss) from discontinued operations (less applicable income tax (provision) benefit of ($55,503), ($1,912,165), ($10,129), and ($3,233,891))		(6,834,187	)		2,597,757			(6,331,029	)		3,932,840
Loss on disposal of discontinued operations		(31,232,934	)		—			(31,601,646	)		—

Income (loss) from discontinued operations, net of tax		(38,067,121	)		2,597,757			(37,932,675	)		3,932,840
Income (loss) from operations before a cumulative effect of a change in accounting principle		(59,219,838	)		(549,751	)		(62,394,934	)		16,675,690

Cumulative effect of a change in accounting principle (net of tax of $661,283)		—			—			—			991,925

Net income (loss)	$	(59,219,838	)	$	(549,751	)	$	(62,394,934	)	$	17,667,615

Basic income (loss) per common share:
Income (loss) from continuing operations before cumulative effect of a change in accounting principle	$	(.31	)	$	(.05	)	$	(.36	)	$	.20
Income (loss) from discontinued operations	$	(.57	)	$	(.04	)	$	(.57	)	$	.06
Cumulative effect of a change in accounting principle		—			—			—		$	.02

Net income (loss)	$	(.88	)	$	(.01	)	$	(.93	)	$	.28

Diluted income (loss) per common share:
Income (loss) from continuing operations before cumulative effect of a change in accounting principle	$	(.31	)	$	(.05	)	$	(.36	)	$	.18
Income (loss) from discontinued operations	$	(.57	)	$	(.04	)	$	(.57	)	$	.05
Cumulative effect of a change in accounting principle		—			—			—		$	.01

Net income (loss)	$	(.88	)	$	(.01	)	$	(.93	)	$	.24

Basic weighted average common shares outstanding		67,263,159			64,482,619			66,842,451			63,011,366
Diluted weighted average common shares outstanding		67,263,159			64,482,619			66,842,451			71,718,631

See accompanying notes to consolidated financial statements.

PAINCARE HOLDINGS, INC.

Consolidated Statements of Cash Flows

For the Six Months Ended June 30, 2007 and 2006 (Unaudited)


	2007			2006
	(unaudited)			(as restated)
Cash flows from operating activities:
Net income (loss)	$	(62,394,934	)	$	17,667,615
Loss (income) from discontinued operations, net of tax		37,932,675			(3,932,840	)
Cumulative effect of a change in accounting principle, net of tax		—			(991,925	)

Income (loss) from continuing operations		(24,462,259	)		12,742,850
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation		901,478			838,405
Amortization		222,600			1,006,957
Impairment charges		15,225,074			—
Fair value of options issued to employees		130,100			(8,729,821	)
Loss on disposal of property and equipment		121,978			—
Amortization of debt discount		499,599			1,330,064
Stock issued for interest payments		194,140			196,050
Derivative benefit		—			(10,492,951	)
Other non-cash transactions		49,555			431,373
Change in operating asset and liabilities:
Accounts receivable		710,402			(1,012,239	)
Deposits and prepaid expenses		330,117			27,259
Other assets		109,722			82,010
Deferred taxes		519,762			3,180,782
Interest payable		2,255,944			—
Income tax payable		(1,445,462	)		409,573
Accounts payable		567,688			(116,310	)

Net cash provided by (used in) operating activities from continuing operations		(4,069,562	)		(105,998	)
Net cash provided by operating activities attributable to discontinued operations		916,492			1,991,534

Net cash provided by (used in) operating activities		(3,153,070	)		1,885,536
Cash flows from investing activities:
Purchase of property and equipment		(330,469	)		(763,796	)
Cash paid for earnouts		(331,122	)		(7,705,992	)
Cash used for acquisitions		—			(9,982,214	)
Cash from disposition		6,771,518			655,556

Net cash provided by (used in) investing activities from continuing operations		6,109,927			(17,796,446	)
Net cash provided by (used in) investing activities attributable to discontinued operations		19,290			(258,506	)

Net cash provided by (used in) investing activities		6,129,217			(18,054,952	)
Cash flows from financing activities:
Proceeds from issuance of common stock, net capital offering costs		—			4,090,707
Payments of capital lease obligations		(633,097	)		(835,812	)
Increase in notes receivable, net of payments		(136,413	)		(637,999	)
Payment on notes payable		(4,486,679	)		(752,000	)
Notes payable issued		—			2,000

Net cash provided by (used in) financing activities from continuing operations		(5,256,189	)		1,866,896
Net cash provided by (used in) financing activities attributed to discontinued operations		(549,802	)		(2,161,233	)

Net cash provided by (used in) financing activities		(5,805,991	)		(294,337	)

Net increase (decrease) in cash and cash equivalents		(2,829,844	)		(16,463,753	)
Cash and cash equivalents at beginning of period includes cash from discontinued operations of $1,292,159 and $2,573,277		3,987,619			22,713,165

Cash and cash equivalents at end of period includes cash from discontinued operations of $226,206 and $1,831,072	$	1,157,775		$	6,249,412

Supplemental disclosures of cash flow information:
Cash paid during the period for interest		1,550,403			2,464,787
Cash received (paid) for taxes		1,026,004			(2,538,328	)
Non-cash investing and financing transactions:
Common stock issued for acquisitions		—			15,922,038
Common stock issued for contingent consideration		322,926			4,858,807
Acquisition consideration payable		811,998			2,154,300
Common stock issued for debenture conversions		—			15,735,237
Equipment purchased financed		229,363			—
Common stock issued for interest		194,140			—

See accompanying notes to consolidated financial statements.

PAINCARE HOLDINGS, INC.

Consolidated Statements of Stockholders’ Equity

For the Three and Six Months Ended June 30, 2007

(Unaudited)


	Common Stock		Additional Paid in Capital		Accumulated Deficit			Accumulated Other Comprehensive Income		Total Stockholders’ Equity
	Shares	Amount	Additional Paid in Capital		Accumulated Deficit			Accumulated Other Comprehensive Income		Total Stockholders’ Equity
Balances at December 31, 2006	66,292,721	6,629	$	142,763,156	$	(45,465,595	)	$	46,792	$	97,350,982
Comprehensive loss:
Net loss						(62,394,934	)				(62,394,934	)
Cumulative translation adjustment									49,555		49,555

Total comprehensive loss											(62,345,379	)
Common stock issued for earnouts- RMG	56,822	6		38,633		—			—		38,639
Common stock issued for earnouts- SOPC	169,376	17		62,652		—			—		62,669
Common stock issued for earnouts- HCCT	620,994	62		198,656		—			—		198,718
Common stock issued for earnouts- APG	61,892	6		22,894		—			—		22,900
Common stock options issued to employees	—	—		130,100		—			—		130,100
Common stock issued for debenture interest payments	330,245	33		194,107		—			—		194,140

Balances at June 30, 2007	67,532,050	6,753	$	143,410,198	$	(107,860,529	)	$	96,347	$	35,652,769

See accompanying notes to consolidated financial statements.

(1) Organization and Basis of Presentation

Basis of Presentation

PainCare Holdings, Inc. (“the Company”) is a provider of pain-focused medical and surgical solutions. Through its proprietary network of acquired or managed physician practices and ambulatory surgery centers, and in partnership with independent physician practices and medical institutions throughout the United States and Canada, PainCare is committed to utilizing the most advanced science and technologies to diagnose and treat pain stemming from neurological and musculoskeletal conditions and disorders.

The accompanying unaudited condensed consolidated financial statement of the Company and its subsidiaries should be read in conjunction with the consolidated financial statements and accompanying notes filed with the U.S. Securities and Exchange Commission (the “SEC”) in PainCare’s 2006 Annual Report on Form-10-K (the “2006 Form 10-K”). The unaudited condensed consolidated financial statements have been prepared in accordance with the rules and regulations of the SEC applicable to interim financial information. Certain information and note disclosures included in financial statements prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”) have been omitted in these interim statements, as allowed by such SEC rules and regulations. The balance sheet as of June 30, 2007 has been derived from unaudited financial statements, but it does not include all disclosures required by GAAP. However, we believe the disclosures are adequate to make the information presented not misleading.

The unaudited results of operations for the interim periods shown in these financial statements are not necessarily indicative of operating results for the entire year. In our opinion, the accompanying condensed financial statements recognize all adjustments for a normal recurring nature considered necessary to fairly state the financial position, results of operations, and cash flows for each interim period presented.

Reclassifications

Certain financial results have been reclassified to conform to the current period presentations. Such reclassifications primarily relate to subsidiaries we sold or have listed as available for sale in the three months ended June 30, 2007 that qualify under Financial Accounting Standards Board (“FASB”) Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, to be reported as discontinued operations. We reclassified our condensed consolidated balance sheet for the year ended December 31, 2006 and our condensed statement of operations’ comprehensive income and statement of cash flows for the six and three months ended June 30, 2006 to show the results of those qualifying subsidiaries. The Company also reclassified these subsidiaries for the six and three months ended June 30, 2007 as discontinued operations.

Use of Estimates

The preparation of financial statements in conformity with United States generally accepted accounting principles requires the Company to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue and expenses, and related disclosure of contingent assets and liabilities. The more significant estimates relate to revenue recognition, contractual allowances and uncollectible accounts, intangible assets, accrued liabilities, derivative liabilities, income taxes, litigation and contingencies. Estimates are based on historical experience and on various other assumptions that the Company believes to be reasonable under the circumstances, the results of which form the basis for judgments about results and the carrying values of assets and liabilities. Actual results and values may differ significantly from these estimates.

Cash and Cash Equivalents

The Company has a qualified cash requirement from the HBK Investments credit facility. This requires the Company to maintain a minimum consolidated balance of $2,000,000 in cash and cash equivalents at all times. As of June 30, 2007 the Company is in default of this covenant.

Accounts Receivable

Accounts receivable, net for continuing operations at June 30, 2007 consisted of:


Accounts receivable	$	9,088,070
Less allowance for doubtful accounts		1,148,006

Accounts receivable, net	$	7,940,064

Property and Equipment

Property and equipment are recorded at cost. Depreciation is computed using the straight-line method over the estimated useful lives of the respective assets. Leasehold improvements are depreciated over the shorter of the term of the lease, including renewal periods when appropriate, or the estimated useful lives of the improvements. Expenditures for repairs and maintenance are charged to expense as incurred. Expenditures for betterments and major improvements are capitalized and depreciated over the remaining useful life of the asset. The carrying amounts of assets sold or retired and related accumulated depreciation are eliminated in the year of disposal and the resulting gains and losses are included in other income or expense. The useful lives of operating equipment range from five to ten years, and the depreciation period for leasehold improvements ranges from three to ten years.

Property and equipment, net for continuing operations at June 30, 2007 consisted of:


Furniture, fixtures equipment	$	6,202,332
Medical equipment		9,111,644

Total cost		15,313,976
Less accumulated depreciation		6,833,841

Property and equipment, net	$	8,480,135

Accounts Payable and Accrued Expenses

Accounts payable and accrued expenses for continuing operations at June 30, 2007 consisted of:


Accounts payable	$	1,822,893
Accrued salaries		437,041
Accrued interest and penalties on ineffective registration statements		1,552,210
Accrued management bonuses		385,000
Other payable and accrued expenses		710,613

Accounts payable and accrued expenses	$	4,907,757

Accrued Interest

Accrued interest for continuing operations at June 30, 2007 consisted of:


Convertible debenture	$	491,200
Accrued interest on note payable		681,715
Accrued forbearance fee		1,665,000
Accrued loan fee		200,000

Accrued Interest	$	3,037,915

Advertising Costs

Advertising expenditures relating to marketing efforts consisting primarily of marketing material, brochure preparation, printing and trade show expenses are expensed as incurred, which is included in general and administrative expense in the accompanying consolidated statements of operations. Advertising expense was $629,051 and $646,545 for the six months ended June 30, 2007 and 2006, respectively. For the three months ended June 30, 2007 and 2006, advertising expense was $289,383 and $382,231, respectively.

Recent Accounting Pronouncements

In February 2007, the FASB issued Statement of Financial Accounting Standards No. 159, “The Fair Value Option for Financial Assets and Liabilities” (“SFAS 159”). SFAS 159 provided entities the one-time election to measure financial instruments and certain other assets and liabilities at fair value on an instrument-by-instrument basis under a fair value option. SFAS 159 is effective for financial statements as of the beginning of the first fiscal year that begins after November 15, 2007. Its provision may be applied to an earlier period only if the following conditions are met: (1) the decision to adopt is made after the issuance of SFAS 159 but within 120 days after the first day of the fiscal year of adoption, and no financial statements, including footnotes, for any interim period of the adoption year have yet been issued and (2) the requirement of SFAS 157 are adopted concurrently with or prior to the adoption of SFAS 159. We are currently evaluating the provisions of SFAS 159.

In December 2006, the FASB approved EITF 00-19-2, “Accounting for Registration Payment Arrangements.” which establishes the standard that contingent obligations to make future payments under a registration rights arrangement shall be recognized and measured separately in accordance with Statement 5 and FASB Interpretation No. 14, Reasonable Estimation of the Amount of a Loss . Early adoption of EITF 00-19-2 is permitted, and the Company has elected such early adoption.

(2) Going Concern

Current situation - August 2007

As of June 30, 2007, the Company had a working capital deficit from continuing operations of $27,073,389 including $931,569 of cash and cash equivalents. The Company’s cash provided by (used in) continuing operating activities for the six months ended June 30, 2007 and 2006, was ($8,867,168) and ($105,998), respectively.

The Company expects to utilize it’s available cash and cash equivalents to fund its operating activities. We have significantly curtailed our acquisition model and have a plan to reduce expenses prospectively. The Company is continuing to pursue fund-raising possibilities through either the sale of its securities, debt financing or asset dispositions. There can be no assurance that we will be able to effectuate any of the foregoing alternatives on terms that we deem to be reasonable given the circumstances. If the Company is unable to effectuate any of the foregoing alternatives on reasonable terms and/or the level of cash and cash equivalents falls below anticipated levels, it is uncertain if we will have the ability to continue our operations as they are currently conducted beyond the second quarter of 2007. The accompanying financial statements have been prepared on the assumption that we will continue as a going concern.

HBK Notice of Default

On March 21, 2007, we received a notice of default (the “HBK Notice”) from HBK Investments L.P. (the “Agent”) with respect to that certain Loan and Security Agreement dated May 11, 2005, as amended (the “Loan Agreement”), entered into by the Company, the Company’s subsidiaries, the Agent, HBK Master Fund L.P., (“HBK-MF”) and Del Mar Master Fund Ltd. (“Del Mar,” and together with HBK-MF the “Lenders”). The HBK Notice provides that (i) the default rate of interest as set forth in the Loan Agreement is in effect until such time as all such alleged events of default have either been cured or waived in writing, and (ii) the Agent and Lenders expressly reserve all of their remedies, powers, rights, and privileges under the Loan agreement, at law, in equity, or otherwise including, without limitation, the right to declare all obligations under the Loan Agreement immediately due and payable. On March 21, 2007, we received a notice from the Agent that the Agent would be charging interest at the default rate until all existing events of default have been waived in accordance with the Loan Agreement. The default rate is LIBOR plus 10.25% or approximately 15.57% as of March 21, 2007. As of June 30, 2007 the principal and accrued interest due was $23,263,321 and $2,546,715.

CPM Notice of Default

On March 15, 2007, we received a notice of breach and default (the “CPM Notice”) from The Center for Pain Management, LLC (“CPM”) with respect to that certain Asset Acquisition Agreement dated December 1, 2004 (the “APA”) entered into by the Company, PainCare Acquisition Company XV, Inc. (the “Subsidiary”), CPM, and the owners of CPM (the “Members”). The CPM Notice provides that unless the alleged events of default set forth in the CPM Notice are cured by the Company, (i) certain non-competition and non-solicitation provisions binding the Members will cease as of April 24, 2007, and (ii) CPM and the Members will have, as of April 12, 2007, certain rights under that certain Stock Pledge Agreement dated December 1, 2004 (the “Pledge Agreement”) entered into by the Company and the Members, including, but not limited to, the right to foreclose on the issued and outstanding shares of stock of the Subsidiary. Since receipt of the CPM Notice we have been actively engaged in negotiations with CPM in an effort to resolve the disputes between us. We have, as a result of the foregoing negotiations, reached an agreement in principal providing for our sale of CPM and the related surgery center operations to those individuals from whom we originally purchased the operations. On May 21, 2007 the original purchase transaction was rescinded and the debt was forgiven.

Convertible Debentures

We are currently in technical default of the terms of the convertible debentures issued to Midsummer Investments, Ltd and Islandia LP, as a result of our default under the terms of the HBK loan facility. We have not, to date, received any formal notification of default from either Midsummer or Islandia.

Liquidated damages on PIPE investments

During 2006, The Company placed a private investment in public equity (PIPE) of $10.2 million. The execution of that equity issuance required The Company to file an effective registration statement for those shares within 90 days. Failure to have an effective registration statement within the prescribed time period has caused The Company to recognize liquidated damages of $1.7 million. The Company is currently in negotiations regarding the timing and method of payment to satisfy the obligation.

(3) Categories of Revenue

We present three categories of revenue in our statement of operations: pain management, surgeries and ancillary services. Pain management revenue is derived from our owned and managed practices, which provide pain management services. Surgery revenue is derived from our owned and managed practices, which primarily provide surgical services. Ancillary service revenue is derived from our owned and managed practices and limited management practices, which provide one or more of our ancillary services, including: orthopedic rehabilitation, electro-diagnostic medicine, intra-articular joint treatment and diagnostic imagery. Our cost of revenue is primarily physicians’ salaries and medical supplies.

We have set forth below our revenues, and operating income (loss) for continuing operations classified by the type of service we perform as well as the expenses allocated to our corporate office.


For the Six Months Ended June 30, 2007
	Pain Management			Surgery			Ancillary Services			Corporate			Totals
Net Revenues	$	12,276,948		$	2,201,365		$	5,466,076		$	—		$	19,944,389
Operating income (loss)	$	(7,992,802	)	$	(3,273,170	)	$	(3,736,881	)	$	(8,058,277	)	$	(23,061,129	)

For the Three Months Ended June 30, 2007
	Pain Management			Surgery			Ancillary Services			Corporate			Totals
Net Revenues	$	6,111,888		$	859,172		$	2,605,306		$	—		$	9,576,366
Operating income (loss)	$	(8,553,864	)	$	(3,095,507	)	$	(4,609,032	)	$	(3,466,053	)	$	(19,724,456	)

For the Six Months Ended June 30, 2006
	Pain Management			Surgery			Ancillary Services			Corporate			Totals
Net Revenues	$	12,339,476		$	3,485,077		$	7,163,899		$	—		$	22,988,452
Operating income (loss)	$	2,101,817		$	794,602		$	1,075,377		$	1,802,986		$	5,774,782

For the Three Months Ended June 30, 2006
	Pain Management			Surgery			Ancillary Services			Corporate			Totals
Net Revenues	$	6,568,065		$	1,604,047		$	2,669,732		$	—		$	10,841,844
Operating income (loss)	$	1,022,082		$	168,488		$	114,907		$	(4,907,557	)	$	(3,602,080	)

Pain management revenue, expense and income are attributable to one owned and nine managed practices that primarily offer physician services for pain management and physiatry. With respect to one of our managed practices, we only include the revenue recognized from management fees earned. Surgery revenue, expense and income are attributable to one owned and two managed physician practices that offer surgical physician services, including minimally invasive spine surgery. Ancillary service revenue, expense and income are attributable to two managed practices that primarily offer orthopedic rehabilitation services. We have 19 practices under limited management agreements, including orthopedic rehabilitation, electro-diagnostic medicine and real estate services.

(4) Income Per Common Share

Basic income per common share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding. The weighted average shares used in computing diluted income per common share include the dilutive effect of stock options, warrants, convertible debt, and other common stock equivalents using the treasury stock method, and income is adjusted for the diluted computation for the assumed non-payment of interest, etc., upon conversion. The shares used in the computation of the Company’s basic and diluted income per common share are reconciled as follows:


	For the Three Months Ended June 30,						For the Six Months Ended June 30,
	2007			2006			2007			2006
Basic earnings per common share
Income (loss) from continuing operations	$	(21,152,717	)	$	(3,147,508	)	$	(24,462,259	)	$	12,742,850
Income (loss) from discontinued operations		(38,067,121	)		2,597,757			(37,932,675	)		3,932,840
Cumulative effect of a change in accounting principle		—			—			—			991,925

Net income available to common shareholders	$	(59,219,838	)	$	(549,751	)	$	(62,394,934	)	$	17,667,615

Weighted average shares		67,263,159			64,482,619			66,842,451			63,011,366
Basic earnings per share:
Income from continuing operations	$	(.31	)	$	(0.05	)	$	(.36	)	$	0.20
Income from discontinued operations	$	(.57	)	$	0.04		$	(.57	)	$	0.06
Cumulative effect of a change in accounting principle	$	—		$	—		$	—		$	0.02

Net income	$	(0.88	)	$	(0.01	)	$	(0.93	)	$	0.28

Diluted earnings per common share
Net income available to common shareholders	$	(59,219,838	)	$	(549,751	)	$	(62,394,934	)	$	17,667,615

Plus impact of assumed conversions:
Interest expense on 7.5% convertible note due 2008, net of tax		—			—			—			225,000
Interest expense on 7.5% convertible note due 2008, net of tax		—			—			—			33,750

Net income available to common shareholders plus assumed conversions	$	(59,219,838	)	$	(549,751	)	$	(62,394,934	)	$	17,926,365

Weighted average shares		67,263,159			64,482,619			66,842,451			63,011,366
Plus incremental shares from assumed conversions:
7.5% convertible note due 2008		—			—			—			4,713,242
7.5% convertible note due 2008		—			—			—			789,474
Employee stock option plan for vested, in the money options		—			—			—			2,612,773
Warrants issued, outstanding, and in the money		—			—			—			256,776
Contingent Shares for acquisitions											335,000

Adjusted weighted average shares		67,263,159			64,482,619			66,842,451			71,718,631
Diluted earnings per share:
Income from continuing operations	$	(.31	)	$	(0.05	)	$	(.36	)	$	0.18
Income from discontinued operations	$	(.57	)	$	0.04		$	(.57	)	$	0.05
Cumulative effect of a change in accounting principle	$	—		$	—		$	—		$	0.01

Net income	$	(0.88	)	$	(0.01	)	$	(0.93	)	$	0.24

Potentially dilutive shares excluded from the calculation

Potential shares where the exercise price is greater than the average market price of common shares:


	2007	2006
Stock options	9,806,961	2,456,713
Stock warrants	1,985,884	1,514,884
Convertible debenture, issued December 17, 2003	4,713,242	—
Convertible debentures, issued July 1, 2004	789,474	—
Convertible debenture, issued August 2, 2006	1,578,947	—

Total	18,874,508	3,971,597


Potential shares excluded in the computation of diluted shares outstanding that are anti-dilutive:
	2007	2006 –
Stock options	129,056	—
Stock warrants	—	—
Contingent shares for acquisitions	883,985	—

Total	1,013,041	—

Total potentially dilutive shares excluded from the calculation	19,887,549	3,971,597

(5) Income Taxes

The income tax benefit (provision) six months ended June 30, 2007 and 2006 from continuing operations consists of the following:


	2007			2006
Current:
Federal	$	3,828,634		$	(3,043,768	)
State		—			—

		3,828,634			(3,043,768	)
Deferred:
Federal		(295,341	)		1,116,464
Deferred valuation allowance		(1,646,840	)		—

		(1,942,181	)		1,116,464

Total	$	1,886,453		$	(1,927,304	)

Income tax benefit (provision) attributable to income before income tax deferred from the amount computed by applying the U.S. Federal income tax rate of 34% to income from operations before taxes as a result of the following for the six and three months ended June 30:


	For the six month ended June 30
	2007			2006
Computed “expected” tax benefit (provision)	$	8,958,562		$	(4,987,852	)
Increase (reduction) in income tax expense resulting from:
Derivative (benefit) expense		—			3,567,603
Derivative interest expense		—			(310,376	)
State income taxes, net of federal income tax benefit		—			(138,615	)
Compensation- incentive stock options		(21,258	)		—
Impairment of intangible assets		(5,176,525	)		—
Valuation allowance on net operating loss, capital loss carry-forward, and NQSO		(1,646,840	)		—
Other, net		(227,486	)		(58,064	)

Total	$	1,886,453		$	(1,927,304	)


	For the three months ended,
	2007			2006
Computed “expected” tax benefit (provision)	$	7,241,786		$	1,568,826
Increase (reduction) in income tax expense resulting from:
Derivative (benefit) expense		—			—
Derivative interest expense		—			(177,271	)
State income taxes, net of federal income tax benefit		—			33,454
Compensation- incentive stock options		(1,687	)		(10,272	)
Impairment of intangible assets		(5,126,162	)		—
Valuation allowance on net operating loss, capital loss carry-forward, and NQSO		(1,643,892	)		—
Other, net		(323,390	)		51,948

Total	$	146,655		$	1,466,685

The tax effects of temporary differences that give rise to significant portions of the deferred tax expense for the six months ended June 30, 2007 are presented below:


	2007
Deferred tax benefit (provision):
Non-cash accrued compensation expense		22,976
Property and equipment, primarily due to accelerated depreciation		21,493
Amortization of the excess of purchase price over fair value of assets acquired		(284,386	)
Amortization of unstated interest on deferred, contingent purchase price payments		(31,122	)
Valuation allowance on NOL carry-forward		(1,646,840	)
Allowance for doubtful accounts		14,678
Other		20,759
Deferred state income taxes		(59,739	)

Total	$	(1,942,181	)

Significant components of the Company’s net deferred tax asset for continuing operations at June 30, 2007 are presented in the following table:


	2007
Deferred tax assets:
Allowance for doubtful accounts	$	472,258
Capital loss carry-forward		1,113,456
Net operating loss carry-forward		9,192,797
Employee compensation and retirement benefits		2,113,958
Valuation allowance on deferred tax assets		(6,316,683	)

Gross deferred tax assets		6,575,786
Deferred tax liabilities:
Fixed assets		2,462,023
State income reserve		400,000
Intangible assets		3,132,796
Other		580,967

Gross deferred tax liabilities		6,575,786

Net deferred tax asset (liabilities)	$	—

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will be realized. Management considers the projected future taxable income and tax planning strategies in making this assessment. At June 30, 2007, the Company had regular tax net operating loss carry-forwards of approximately $43.8 million and capital loss carry-forwards of approximately $2.8 million. These loss carry-forward amounts will begin to expire during 2027 and 2011, respectively. In accordance with SFAS “109”- Accounting for Income Taxes, the Company does not believe these tax loss carry-forwards will be realizable. Therefore, the deferred tax assets related to both net operating and capital losses have a valuation allowance provided up to the limit of the deferred tax liabilities. This resulted in a current tax benefit.

(6) Goodwill

The Company continually evaluates the performance of our individual practices. Any practice that is deemed to be underperforming will become subject to more direct oversight by our management team. To the extent additional oversight fails to improve the practice’s performance over a period of time, the practice will become subject to additional company imposed actions, but not limited to, potential restructuring or divestiture. Due to this analysis, the company impaired the following continuing operations; Associated Physicians Group, Colorado Pain Specialists, Piedmont Center for Spinal Disorders and Rocky Mountain Pain Consultants

The changes in the carrying amount of goodwill at June 30, 2007:


	2007
Balance, beginning of year	$	56,455,055
Contingent consideration		783,238
Impairment		(15,076,947	)

Goodwill at end of period	$	42,161,346

Of the total impairment in 2007, an additional $5,795,984 is included in discontinued operations in the accompanying statement of operations.

(7) Dispositions

On February 28, 2007, the PainCare Holdings Inc. parties and Centeno Shultz, Inc. (“CSI”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets of the PainCare Sub for purchase price of the lesser of $250,000 or the total amount of proceeds generated from the sale of certain shares of common stock of PainCare ( the “PainCare Shares”) issued to the Centeno Parties in the Purchase Transaction, and (ii) in exchange for the PainCare parties to terminate the Management Agreement and any and all other agreements between CSI and the PainCare Parties, CSI paid the PainCare Parties $750,000 plus all remaining proceeds in excess of $250,000 from the sale of the PainCare shares. In connection with the termination of the Management Agreement, CSI entered into a promissory note with a principal balance of $375,000 with imputed interest of 8.25% payable by June 1, 2008. As of June 30, 2007, PainCare has received $1,134,725 from the Centeno Parties, in cash payments for the sale of the “Original Practice”, with a receivable balance of $293,923 on the promissory note. The note includes imputed interest of $9,346 at June 30, 2007.

On April 30, 2007, the PainCare Holdings Inc. parties and Georgia Pain Physicians, PC, (“GPP”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for a purchase price of $125,000. $50,000 is due at closing and the remaining balance is a $75,000 promissory note payable in three consecutive installments of $25,000 a month starting June 1, 2007 and paid in full no later than August 1, 2007. Due to the immaterial nature, interest is not imputed on this note. As of June 30, 2007, the PainCare Inc. parties have received $25,000 in payments on the note leaving a remaining balance of $50,000.

On May 21, 2007, the PainCare Holdings Inc. parties and Kenneth Alo, M.D.,P.A.,(“ALO”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $200,000, due at closing, along with a promissory note in the amount of $200,000 to be repaid with interest in six consecutive installments of $34,510 beginning on June 15, 2007. As of June 30, 2007, the PainCare, Inc. parties have received $34,510 in cash payments for the sale of the PainCare Sub leaving a remaining balance on the note in the amount of $167,490.

On May 22, 2007, PainCare Holdings Inc. parties and The HealthCare Center of Tampa, (“HCCT”), entered into a Settlement Agreement and several ancillary documents, pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for a purchase price of $440,000 at closing and agreed to remit the proceeds from the sale of his 685,000 shares of common stock in PainCare Holdings, Inc. HCCT purchased from PainCare and PainCare Sub certain medical equipment for a purchase price of $35,000.

On May 21, 2007, the PainCare Holdings Inc. parties and The Center for Pain Management ASC, LLC (“CPM ASC”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, the Original Surgery Center cancelled the portion of the unpaid amounts owing under the purchase promissory note issued by PainCare Surgery Centers to the Original Surgery Center in the amount of $7.5 million plus all accrued interest.

On May 21, 2007, the PainCare Holdings Inc. parties and The Center for Pain Management, LLC, (“CPM”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $5 million with a forgiveness of certain liabilities and contingent considerations in the amount of $2.4 million. Of the total proceeds from the sale of CPM, $4.7 million went directly to our senior lender HBK Investments to partially repay the remaining principal on the promissory note.

(8) Related Party Transactions

During the six months ended June 30, 2007 and 2006 the Company had transactions with companies owned by certain shareholders of the Company. The following is a summary of transactions with these entities


Practice Name	Type of Practice	Type of Related Party Transaction	Expense related to the six months ended June 30;
Practice Name	Type of Practice	Type of Related Party Transaction	2007		2006		Reported As
Associated Physicians Group, Ltd.	Managed Practice	The Company leases its office space from a limited liability company partially owned by a certain shareholder of the Company. The lease commenced January 1, 2005, for an initial term of ten years with the option to renew for two five year periods. The limited liability company sold the property during the second quarter of 2006.	$	—	$	73,590	G&A

The Center for Pain Management, LLC	Managed Practice	The Company leases certain employees from a limited liability company owned by certain shareholders of the Company. The Company also charged this entity for the use of its equipment and certain services.	$	851,502	$	1,154,901	G&A

May 21,2007 Disposal		The Company has an agreement to outsource its billing and collections function to a limited liability company owned by certain shareholders of the Company. The Company is charged a fee of 8% of net collections under this arrangement.	$	276,912	$	404,411	G&A
		* (A)
		* (B)

Dynamic Rehabilitation Centers, Inc.	Managed Practice	The Company leases its office space from a limited liability company partially owned by certain shareholders of the Company. The lease associated with the Redford location has a ten year term commencing January 1, 2000, with no option to renew. The lease associated with the Clinton Township location commenced October 8, 2004 and expires December 31, 2014. The lease was amended in July 2005, for the occupancy of additional space by the Company.	$	91,275	$	84,444	G&A

		The Company provides services for billing, accounting and management oversight to a limited liability company owned by certain shareholders of the Company.	$	—	$	495,007	G&A
		* (C)

Health Care Center of Tampa, Inc. May 22, 2007 Disposal	Owned Practice	The Company has an agreement to outsource its billing and collections function to a limited liability company owned by a certain shareholder of the Company. The Company is charged a fee of 10% of net collections under this arrangement.	$	77,556	$	159,418	G&A

Rick Taylor, D.O., P.A.	Managed Practice	The Company has an agreement to lease an aircraft from a limited liability company owned by a certain shareholder of the Company. The lease agreement was entered into in June 2003 for a period of 60 months. Effective January 1, 2005, the lease payment was lowered to a nominal amount of $1 per year; the Company will continue to pay a third party provider for the related fuel and maintenance cost.	$	1	$	1	G&A

Spine and Pain Center, P.C.	Managed Practice	The Company leases its office space from a limited liability company partially owned by certain shareholders of the Company. The lease commenced December 23, 2003 and expires December 31, 2008, with no option to renew.	$	54,998	$	63,348	G&A


Practice Name	Type of Practice	Type of Related Party Transaction	Expense related to the six months ended June 30;
Practice Name	Type of Practice	Type of Related Party Transaction	2007		2006		Reported As
Lake Worth Surgical Center Available for Sale	Managed Practice	The Company, through a subsidiary, is the majority partner of the PSHS Alpha Partners, Ltd. Partnership Dr. Merrill Reuter , the Company’s chairman, is a minority partner of the partnership. The Company owns 67.5% and Dr. Reuter owns 9.75% of the partnership. Dr. Reuter receives distributions from the partnership. These distributions are reported as minority interest on the balance sheet.	$	86,775	$	66,300	G&A

The Center for Pain Management ASC, LLC May 21, 2007 Disposal	Managed Practice	The Company leases certain employees from a limited liability company owned by certain stockholders of the Company. The Company also charged this entity for the use of its equipment and certain services.	$	407,813	$	614,432	G&A

The Center for Pain Management ASC, LLC May 21, 2007 Disposal	Managed Practice	The Company has an agreement to outsource its billing and collection functions to a limited liability company owned by certain stockholders of the Company. The Company is charged a flat fee of $40,000 per month under the arrangement.	$	187,097	$	240,000	G&A

The Center for Pain Management ASC, LLC May 21, 2007 Disposal	Managed Practice	The Company has an agreement to outsource its non-clinical management and administrative services and support for health care providers to a limited liability company owned by certain stockholders of the Company. The Company is charged a flat fee of $52,500 per month under this arrangement.	$	245,565	$	315,000	G&A

Georgia Pain Physicians, P.C. April 30, 2007 Disposal	Managed Practice	The Company has agreements to lease equipment from a limited partnership wholly owned by Dr. Windsor. The lease commenced February 1, 2006, with no expiration date.	$	8,050	$	21,250	G&A

Piedmont	Managed Practice	The Company has an agreement to lease property from a limited liability company which is owned by Dr. Cohen. The lease commenced November 1, 2002 and will expire October 31, 2007.	$	54,440	$	32,850	G&A

CareFirst	Managed Practice	The Company has an agreement to lease property from REC, Inc., in which Dr. Carpenter is the President. The lease commenced on January 4, 2006 and will expire on January 3, 2011.	$	24,524	$	14,000	G&A

Northeast Pain Management	Owned Practice	The Company has an agreement to lease property from a limited liability company in which the Zolper family is the sole proprietor. The lease commenced on October 1, 2005 and will expire on September 30, 2007.	$	71,911	$	61,638	G&A

Bone and Joint Clinic	Owned Practice	The Company has an agreement to lease property from Dr. Cenac, the sole owner of such property. The lease commenced on January 1, 2004 and will expire on December 31, 2008.	$	31,596	$	—	G&A

The Center for Pain Management/Care First Practice	Managed Practice	The Center for Pain Management entered into an agreement, through its limited liability company, to handle all billing services for CareFirst Medical Associates and Pain Rehabilitation. The agreement commenced on June 12, 2006 and will expire on June 11, 2011.	$	38,236	$	—	G&A

Georgia Pain Physicians, P.C. April 30, 2007 Disposal	Owned Practice	The Company entered into property lease agreements with Windsor Family Limited Partnership leasing both a storage unit and office space with commencement dates of September 30, 2003 and June 1, 2006 respectively. These leases expire September 30, 2008 and June 1, 2011, respectively.	$	12,653	$	9,463	G&A

Bone and Joint Clinic	Owned Practice	Dr. Cenac entered into an agreement to lease office space to his son. The lease commenced on September 1, 2005 and expired on December 31, 2006.	$	—	$	150,000	G&A

Health Care Center of Tampa, Inc. May 22, 2007 Disposal	Owned Practice	The Company entered into a property leasing agreement with Dr. Khan leasing office space with a commencement date of January 1, 2004. The lease expires on December 31, 2008.	$	54,501	$	58,255	G&A

CareFirst	Managed Practice	The Company has an agreement to lease property from REC, Inc., in which Dr. Carpenter is the President. The lease commenced on April 1, 2007 and will expire on March 31, 2012.	$	7,700	$	—	G&A

(A)

The Company has the option to purchase a “Competitive Business Opportunity” (CBO) from shareholders of the Company who are currently operating a competitive physician practice that fall outside a ten mile radius from the Center for Pain Management, LLC clinics. The Company has an option to purchase the CBO at market rates similar to the original acquisition. There is no guarantee that the option will be exercised by the Company, nor is the purchase price discounted for the Company should they choose to execute the option to purchase.

(B)

The Company has the option to purchase a “Competitive Business Opportunity” (CBO) from shareholders of the Company who are currently operating a competitive surgery center that fall outside a ten mile radius from the Center for Pain Management, LLC clinics. The Company has an option to purchase the CBO at market rates similar to the original acquisition. There is no guarantee that the option will be exercised by the Company, nor is the purchase price discounted for the Company should they choose to execute the option to purchase.

(C)

The Company has the option to purchase a “Competitive Business Opportunity” (CBO) from shareholders of the Company who are currently operating competitive rehabilitation clinics that fall outside a ten mile radius from the Dynamic Rehabilitation Centers, Inc. The Company has an option to purchase the CBO at market rates similar to the original acquisition. There is no guarantee that the option will be exercised by the Company, nor is the purchase price discounted for the Company should they chose to execute the option to purchase.

(9) Acquisition Payable

Acquisition payable at June 30, 2007:


	Cash		Stock		Total
Pain Care Clinics	$	52,162	$	7,720	$	59,882
Northeast Pain Management		291,666		43,767		335,433
Dynamic		125,568		18,584		144,152
RMG		102,720		—		102,720
CareFirst Medical Assoc.		145,828		23,983		169,811

Total	$	717,944	$	94,054	$	811,998

(10) Other Assets

The Company entered into a distribution agreement with MedX96, Inc. on May 1, 2002. The agreement allowed the Company to market and sell MedX equipment in return for a 50% commission of the gross selling price of all equipment sold to the Company and our affiliates. MedX96, Inc. received 15% of the revenue generated by the Company and our affiliates. The equipment is used to provide orthopedic rehabilitation services in our owned, managed, and limited managed physician practices. The contract was amended on July 28, 2003 and provides for the Company to repurchase MedX’ rights to 15% of the gross collections generated by the limited managed orthopedic rehabilitation practices. In addition, the Company receives a 25% commission on all MedX products purchased for resale. This contract right is being amortized over the contract term of ten years.

The Company purchased from Rehab Management Group, Inc., a South Carolina based corporation (“RMG”), all rights, title and interest that RMG owns or acquires and all management fees, revenues, compensation and payments of any kind with respect to three electro-diagnostic management agreements with physician’s practices. These contract rights are amortized over ten years.

The separately identifiable intangible asset is the physicians’ referral network. The referral network represents other doctors in the community who refer their patient base to the Company’s physicians who practice in a discipline to meet their patient’s needs. The Company believes the value of each physician’s referral network is clearly linked to the physicians’ employment agreements. The amortization term is seven years which represents the five year employment agreement the Company enters into with each physician plus the two years of an additional non-compete agreement. The value of the referral network should be amortized over the employment term and the non-compete period of the physician since that represents the period of time the Company benefits from the arrangement.

The Company evaluates the recoverability of the carrying value of its long-lived assets based on estimated undiscounted cash flows to be generated from such assets in accordance with Statement of Financial Accounting Standards (“SFAS”) No. 144 — “Accounting for the Impairment or Disposal of Long-Lived Assets,”If the undiscounted cash flows indicate impairment then the carrying value of the assets being evaluated is impaired to the estimated fair value of those assets. In assessing the recoverability of these assets, the Company must project estimated cash flows which are based on various operating assumptions including the ability of asset to meet budget targets due to changes in payer mix, gross billings, and expenses. Management develops these cash flow projections on a periodic basis and reviews the projections based on actual operating trends. The projections assume that general economic conditions will continue unchanged throughout the projection period and that their potential impact on capital spending and revenues will not fluctuate. Projected revenues are based on the Company’s estimate of the assets’ ability to meet specified budgets. Projected revenues assume a leveling or flattening of revenues at a rate lower than originally realized. Projected operating expenses are based upon historic experience and expected market conditions adjusted to reflect an expected decrease in expenses resulting from cost saving initiatives.

The Company’s review of the carrying value of its long-lived assets at June 30, 2007 indicates that the carrying values of some of these assets are not recoverable through future estimated cash flows. If the cash flow estimates, or the significant operating assumptions upon which they are based, change in the future, the Company may be required to record additional impairment charges related to its long-lived assets.

Due to litigation with Associated Physicians Group (APG) and Colorado Pain Specialists (CPS), the Company is required to impair the physicians referral network. The total impairment charge was $148,127 which is included in the line item Impairment for continuing operations of the Consolidated Statement of Operations. The impairment charge of $70,038 for APG is included in the ancillary segment and the $78,089 charge for CPS is included in the pain segment.

The Company performed the analysis on each of its intangible assets and determined there was impairment which was recorded during the six months ended June 30, 2007.

Other assets at June 30, 2007:


	Cost		Amortization		Net
MedX Distribution Right	$	2,212,672	$	1,670,209	$	542,463
Contract Right-APG		482,107		252,816		229,291
Contract Right-SPA		1,419,471		318,442		1,101,029
Contract Right-SCPI		1,041,545		277,214		764,331
Physician’s referral network		1,524,827		865,974		658,853

Totals	$	6,680,622	$	3,384,655	$	3,295,967

Estimated amortization of intangible assets for each of the next five years is as follows:


	Amortization of intangible assets
2007	$	495,119
2008		485,522
2009		481,283
2010		457,123
2011		394,217

(11) Pro Forma

Pro Forma Consolidated Statement of Operations for the six months ended June 30, 2007 represents financial results for continuing and discontinued operations as estimated for those entities had they not been classified as held for sale or sold during the period. The financial results for PainCare Surgery Centers, Inc., for the six months ended June 30, 2007 were the actual financial results, which was included in discontinued operations due to PainCare’s intent to sell.


	For the six months ended June 30, 2007
	PainCare Actual			Centeno			GPP			Alo			Khan			CPM			CPM ASC		PCSI			Adjustments^(a)			ProForma
Revenues	$	19,944,389		$	1,152,456		$	1,977,093		$	431,033		$	1,134,484		$	5,102,936		$	3,112,286	$	4,347,089			—		$	37,201,766

Cost of revenues and operating expenses		43,005,518			1,236,584			2,279,753			458,846			1,670,101			3,002,412			1,827,618		8,371,882			—			61,852,714

Operating income (loss)		(23,061,129	)		(84,128	)		(302,660	)		(27,813	)		(535,617	)		2,100,524			1,284,668		(4,024,793	)		—			(24,650,948	)

Interest income (expense)		(3,277,368	)		(549	)		(325	)		—			—						—		(3,344	)		(2,839,158	)		(6,120,744	)

Other income (expense)		(10,215	)		—			2,027			454			(529	)		(337	)		—		19,869						11,269

Income (loss) before taxes		(26,348,712	)		(84,677	)		(300,958	)		(27,359	)		(536,146	)		2,100,187			1,284,668		(4,008,268	)		(2,839,158	)		(30,760,423	)

Benefit (provision) for income taxes		1,886,453			—			—			(10,129	)		—			—			—		—			—			1,876,324

Income before minority interest		(24,462,259	)		(84,677	)		(300,958	)		(37,488	)		(536,146	)		2,100,187			1,284,668		(4,008,268	)		(2,839,158	)		(28,884,099	)

Minority interest		—			—			—			—			—			—			—		851,077			—			851,077

Net income (loss)	$	(24,462,259	)	$	(84,677	)	$	(300,958	)	$	(37,488	)	$	(536,146	)	$	2,100,187		$	1,284,668	$	(4,859,345	)	$	(2,839,158	)	$	(29,735,176	)

Pro Forma Consolidated Statement of Operations for the six months ended June 30, 2006 represents financial results for continuing, and discontinued operations. The financial results for Physiom, Centeno Shultz, Inc., Georgia Pain Physicians, PC, Kenneth Alo, M.D., P.A., HealthCare Center of Tampa, The Center for Pain Management, LLC, and The Center for Pain Management ASC, LLC, for the six months ended June 30, 2006 are the actual results.


	For the six months ended June 30, 2006
	PainCare Actual			Physiom			Centeno			GPP			Alo			Khan			CPM			CPM ASC			PCSI			Adjustments^(a)			ProForma
Revenues	$	22,988,452		$	2,167,549		$	2,114,266		$	2,946,568		$	1,175,973		$	1,553,789		$	5,584,570		$	2,991,125		$	5,377,494			—		$	46,899,786

Cost of revenues and operating expenses		17,213,670			908,642			1,014,007			2,634,086			633,375			931,163			3,083,727			1,985,060			2,807,405			—			31,211,135

Operating income (loss)		5,774,782			1,258,907			1,100,259			312,482			542,598			622,626			2,500,843			1,006,065			2,570,089			—			15,688,651

Interest income (expense)		(2,038,000	)		—			(4,375	)		(855	)		—			(670	)		102			—			(7,006	)		(1,977,111	)		(4,027,915	)

Derivative benefit		10,492,951			—			—			—			—			—			—			—			—			—			10,492,951

Other income (loss)		440,421			—			—			2,689			—			—			—			—			10,427			—			453,537

Income (loss) before taxes		14,670,154			1,258,907			1,095,884			314,316			542,598			621,956			2,500,945			1,006,065			2,573,510			(1,977,111	)		22,607,224

Benefit (provision) for income taxes		(1,927,304	)		(428,752	)		(374,133	)		(121,274	)		(202,894	)		(231,079	)		(850,840	)		(411,282	)		(613,637	)		—			(5,161,195	)

Income before minority interest		12,742,850			830,155			721,751			193,042			339,704			390,877			1,650,105			594,783			1,959,873			(1,977,111	)		17,446,029

Minority interest		—			—			—			—			—			—			—			—			770,339			—			770,339

Net income (loss)	$	12,742,850		$	830,155		$	721,751		$	193,042		$	339,704		$	390,877		$	1,650,105		$	594,783		$	1,189,534		$	(1,977,111	)	$	16,675,690

(a)	Interest was allocated at $2,839,158 and $1,977,111 for the six months and three months ended June 30, 2007 respectively.

(12) Long-Term Debt

Long-term debt consists of the following at June 30, 2007:


HBK Investments (a)	$	22,436,759
Less Current Installments		22,436,759

Total, long term	$	—

At June 30, 2007, the aggregate annual principal payments with respect to the obligations existing at that date as described above are as follows:


Six Months Ending June 30:
2007	$	23,263,320
2008
2009
Thereafter
Less unamortized discount		826,561

Total	$	22,436,759

(a)

Note payable to HBK Investments is callable currently due to the existence of events of default under the loan agreement and the forbearance agreement dated January 1, 2007. On March 21, 2007, the Agent provided the Company with notice that the Agent would be charging interest at the default rate until all existing events of default have been met or waived in accordance with the loan agreement. The default rate is LIBOR plus 10.25% or approximately 15.57% as of March 21, 2007. Interest payments are due monthly. The interest payments due on June 1, 2007 was not paid and will be added to the principal balance. Certain mandatory prepayments must be made upon the occurrence of any sale or disposition of property or assets, upon the receipt of any extraordinary receipts, and upon issuance of any indebtedness other than indebtedness permitted by the agreement, including equipment leases and notes. Certain divestitures were made during the year, which HBK has agreed to allow the Company to keep the proceeds. On May 2, 2006, June 20, 2006, August 9, 2006 and November 8, 2006 we entered into letter agreements with the lenders under the credit facility in consideration for which we paid $300,000, $150,000, $100,000 and $150,000 in waiver fees, respectively, to the lenders. For the six months ending June 30, 2007, $1,865,000 was expensed to interest with a monthly forbearance fee of $277,500 and a one time loan cost of $200,000. The Face value of the Note is $23,263,320 with unamortized discount of $826,561. The total amount amortized to interest expense for the six months ended June 30, 2007 was $370,061. We are currently engaged in negotiations with the Agent in an effort to restructure the debt and related loan agreements.

(13) Convertible Debentures

Convertible Debentures consist of the following at June 30, 2007:


Midsummer/Islandia (a)	$	8,658,482
Midsummer (b)		1,456,400
Midsummer/Islandia (c)		2,724,472

Total		12,839,354
Less current installments		12,839,354

Long-term portion	$	—


Maturities of the convertible debentures for future years ending June 30, are as follows:
2007	$	13,455,160	(d)
2008		—
2009		—
2010		—
2011		—
Less unamortized discount		615,806

Total	$	12,839,354

(a)

Convertible debenture to Midsummer Investment Ltd. in the original amount of $5,000,000 and Islandia, LP in the original amount of $5,000,000. The Company combines these debentures since they are of identical terms. On July 1, 2004, Midsummer Investment, Ltd. converted $1,044,840 of their debenture into 400,000 Company shares. Their face value is currently $3,955,160. The Islandia, LP debenture has a face value currently of $5,000,000. These two debentures were completed on the same date of December 17, 2003 with an original maturity date of December 17, 2006. On August 2, 2006, the Company extended the term of these debentures to August 2, 2009. The extension did not change the face value or the interest rate. The stated interest rate is 7.5%. The interest expense for the six months ending June 30, 2007, was $335,850. The debentures are convertible into common stock of the Company at the price of $1.90 per share. There are no assets pledged as collateral, sinking fund requirements, or restrictive covenants associated with these debentures. The amount of amortized discount accreted to interest expense in the six months ending June 30, 2007 was $71,200. The June 30, 2007 unamortized discount balance is $296,678.

(b)

Convertible debenture to Midsummer Investment Ltd. in the face amount of $1,500,000. The debenture was completed on July 1, 2004 with an original maturity date of June 30, 2007. On August 2, 2006 the Company extended the term of this debenture to August 2, 2009. The extension did not change the face value or the interest rate. The stated interest rate is 7.5%. The interest expense for the six months ending June 30, 2007 was $56,250. The debentures are convertible into common stock of the Company at the price of $1.90 per share. There are no assets pledged as collateral, sinking fund requirements, or restrictive covenants associated with this debenture. The amount of amortized discount accreted to interest expense in the six months ending June 30, 2007 was $142,755. The June 30, 2007 unamortized discount balance is $43,599.

(c)

Convertible debenture to Midsummer Investment Ltd. with a face value of $1,500,000 and Islandia, LP with a face value of $1,500,000. The Company combines these debentures since they are of identical terms. These two debentures were completed on the same date of August 2, 2006 with an original maturity date of August 2, 2009. The stated interest rate is 8.5%. The interest expense for the six months ending June 30, 2007 was $127,500. The debentures are convertible into common stock of the Company at the price of $1.90 per share. There are no assets pledged as collateral, sinking fund requirements, or restrictive covenants associated with these debentures. The amount of amortized discount accreted to interest expense in the six months ending June 30, 2007 was $195,969. The June 30, 2007 unamortized discount balance is $275,529. The convertible debentures issued to Midsummer Investments, Ltd and Islandia LP. are currently in technical default because the Company is in default with it’s primary lender. As of August 14, 2007, the Company has not received formal notification of default. Additionally, the Company is prohibited from paying interest on these obligations due to the notice provided by HBK under the intercreditor agreement with the holders of these debentures.

(d)

As a result of certain technical defaults under the terms of the convertible debentures issued to Midsummer Investments, Ltd and Islandia LP, all amounts outstanding under the convertible debentures are treated as current liabilities. As of August 14, 2007, the Company has not received formal notification of default. Additionally, the Company is prohibited from paying interest on these obligations due to the notice provided by HBK under the intercreditor agreement with the holders of these debentures.

(14) Litigation

Class Action

On March 21, 2006, Roy Thomas Mould filed a complaint under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 against the Company, as well as the Company’s chief executive officer and chief financial officer, before the United States District Court for the Middle District of Florida. The complaint is entitled Mould v. PainCare Holdings, Inc., et al. , Case No. 06-CV-00362-JA-DAB. Mr. Mould alleged material misrepresentations and omissions in connection with the Company’s financial statements which appear to relate principally to the Company’s previously announced intention to restate certain past financial statements. Ten additional complaints were filed shortly afterward before the same court which recite similar allegations. (Collectively, these cases will be referred to as the “Securities Litigation.”) Lead counsel was selected and a consolidated complaint was filed. On September 20, 2006, the Company filed a motion to dismiss the pending securities class action with the Federal District Court. Subsequently, the District Court referred the matter to a Federal Magistrate for a hearing, report and recommendation. On January 17, 2007, the Magistrate held a hearing and took the matter under submission. On March 26, 2007, the Magistrate issued a report which recommended that the District Court dismiss all outstanding claims with leave to amend. On April 25, 2007, the District Court signed an order adopting the Magistrate’s report and dismissed the Securities Litigation, with leave to amend. An amended consolidated class action complaint was filed on May 23, 2007. By motion filed June 7, 2007, the Company again moved to dismiss the action. The Magistrate held a hearing regarding the Company’s dismissal motion at the conclusion of the hearing, the matter was taken under submission by the Magistrate on August 15, 2007.

Derivative Action

On April 7, 2006, Kenneth R. Cope filed a derivative complaint against the directors of the Company before the United States District Court for the Middle District of Florida. The complaint is entitled, Cope v. Reuter, et al. , Case No. 06-CV-00449-JA-DAB. Mr. Cope alleges that the directors breached their fiduciary duties by failing to supervise and manage the operations of the company, among other claims. (This litigation is referred to as the “Derivative Action.”). In November of 2006, the Company and the plaintiff entered into a Stipulation and Agreement of Compromise, Settlement and Release, filed on November 30, 2006, and conditioned upon court approval. Concurrently with the filing of the foregoing agreement, the parties jointly moved for preliminary court approval, and thereafter, for final approval following notice to the Company’s shareholders. The Stipulation and Agreement was preliminarily approved by the court on January 12, 2007, and finally approved on April 20, 2007, at which time the Derivative Action was dismissed.

Other Matters

Additional disclosure regarding the foregoing litigation and other litigation involving the Company is set forth in the Company’s annual report on Form 10-K for the year ended December 31, 2006.

(15)

Stock Options and Warrants

The Company’s previously issued consolidated financial statements as of and for the quarters ending March 31, June 30, and September 30, 2006 have been restated to give effect to the correction of certain errors that were discovered subsequent to September 30, 2006. See Footnote 3 Restatement and Reclassifications of Previously Issued Financial Statements in the Company’s 10-K for the year ended December 31, 2006 for further explanation.

The Company’s Board of Directors adopted the 2000 Stock Option Plan and the 2001 Stock Option Plan (the “Plans”) which authorize the issuance of up to 10,000,000 shares of the Company’s common stock to employees, non-employees and Directors. There are also option grants totaling 2,000,000 shares of common stock made to executive officers that were issued outside of the two Plans. Options granted under the Plans and to the executives are exercisable up to 10 years from the grant date at an exercise price of not less than the fair market value of the common stock on the date of grant.

Notwithstanding, the term of an incentive stock option granted under the Plan to a stockholder owning more than 10% of the voting rights may not exceed 5 years, and the exercise price of an incentive stock option granted to such stockholder may not be less than 110% of the fair market value of the common stock on the date of grant.

Warrants were issued for various capital raising purposes and for consulting fees.

The number of shares, terms, vesting and exercise period of options granted under the Plans are determined by the Company’s Board of Directors on a case-by-case basis.

Stock options and warrants granted, exercised and expired during the year ended December 31, 2006 and for the six months ended June 30, 2007 are as follows:


	Options			Warrants
	Number	Weighted Average Exercise Price		Number		Weighted Average Exercise Price
Outstanding, December 31, 2005	9,752,150	$	1.98	3,179,316	(a)	$	2.61
Granted in 2006	565,000	$	1.58	1,399,884		$	3.51
Exercised in 2006	—	$	—	—		$	—
Forfeited in 2006	520,000	$	2.35	2,678,316		$	2.84

Outstanding, December 31, 2006	9,797,150	$	1.94	1,900,884		$	2.96

Granted in 2007	421,500	$	.55	—		$	—
Exercised in 2007	—	$	—	—		$	—
Forfeited in 2007	100,000	$	1.64	—		$	—

Outstanding, June 30, 2007	10,118,650	$	1.88	1,900,884		$	2.96

Exercisable at June 30, 2007	9,931,980	$	1.90	1,900,884		$	2.96

(a)	includes 25,000 warrants issued to employees.

The following table summarizes information for options and warrants outstanding and exercisable at June 30, 2007:


Exercise Price	Number Outstanding	Weighted Average Remaining Life	Number Outstanding and Exercisable	Weighted Average Remaining Life
Stock Options:
$0.25-$1.00	3,613,650	.72	3,546,980	.64
$1.01-$2.00	3,250,000	4.75	3,130,000	4.77
$2.01-$3.00	1,665,000	1.50	1,665,000	1.50
$3.01-$4.00	1,410,000	3.75	1,410,000	3.75
$4.01-$5.00	155,000	2.73	155,000	2.73
$5.01-$6.00	25,000	2.51	25,000	2.51

Total	10,118,650	2.59	9,931,980	2.56

Warrants:
$0.25-$1.00	106,000	1.5	106,000	1.5
$1.01-$2.00	330,000	.9	330,000	.90
$2.01-$3.00	—	—	—	—
$3.01-$4.00	1,414,884	.17	1,414,884	.17
$4.01-$5.00	50,000	3.5	50,000	3.5
$5.01-$6.00	—	—	—	—

Total	1,900,884	.81	1,900,884	.81

The weighted-average grant-date fair value of options and warrants granted during the six months ending June 30, 2006 and 2007 were $.69 and $.28, respectively. There were no options exercised in the quarters ending June 30, 2006 and 2007.

A summary of the status of the Company’s non-vested options as of June 30, 2007, and changes since the year ended December 31, 2006 is presented below:


	Number of Options		Weighted Average Grant Date Fair Value
Outstanding, December 31, 2005	2,891,733		$	1.08
Granted in 2006	204,167		$	.80
Vested in 2006	(2,666,731	)	$	1.05
Forfeited in 2006	(54,999	)	$	1.23

Outstanding, December 31, 2006	374,170		$	1.08
Granted in 2007	66,667		$	.32
Vested in 2007	(187,500	)	$	1.41
Forfeited in 2007	(66,667	)	$	.80

Outstanding, June 30, 2007	186,670		$	.57

As of June 30, 2007, there was $131,445 of total unrecognized compensation cost related to non-vested share based compensation arrangements. The cost is expected to be recognized over a weighted-average period of .77 years.

During the second quarter of 2006, the Company fully vested options on 2,155,000 shares of common stock held by the CEO, CFO, and President. As a result of that modification, the Company recognized additional compensation expense of $1,125,250 for the year ended December 31, 2006.

(16) Segment Reporting

We define segment operating earnings as income before (1) interest income; (2) interest expense and amortization of debt discount and fees; (3) gain or loss from discontinued operations; and (4) income tax expense or benefits. We also do not allocate corporate to our operating segments. We use segment operating earnings as an analytical indicator for purposes of allocating resources to a particular segment and assessing segment performance. Revenues and expenses are measured in accordance with the policies and procedures described in Note 1, Summary of Significant Accounting Policies, to the consolidated financials statements accompanying our 2006 Form 10-K.

Selected financial information of our operating segments for the six months ended June 30, 2007 and the three months ended June 30, 2007 are as follows:


	Pain Management			Surgery			Ancillary Services			Corporate and Other			Total
Six Months ended June 30, 2007
Net revenues	$	12,276,948		$	2,201,365		$	5,466,076		$	—		$	19,944,389
Operating income (loss)	$	(7,992,802	)	$	(3,273,170	)	$	(3,736,881	)	$	(8,058,277	)	$	(23,061,129	)
Three Months ended June 30, 2007
Net revenues	$	6,111,888		$	859,172		$	2,605,306		$	—		$	9,576,366
Operating income (loss)	$	(8,553,864	)	$	(3,095,507	)	$	(4,609,032	)	$	(3,466,053	)	$	(19,724,456	)

Selected financial information of our operating segments for the six months ended June 30, 2006 and the three months ended June 30, 2006 is as follows:


	Pain Management		Surgery		Ancillary Services		Corporate and Other			Total
Six Months ended June 30, 2006
Net revenues	$	12,339,476	$	3,485,077	$	7,163,899	$	—		$	22,988,452
Operating income (loss)	$	2,101,817	$	794,602	$	1,075,377	$	1,802,986		$	5,774,782
Three Months ended June 30, 2006
Net revenues	$	6,568,065	$	1,604,047	$	2,669,732	$	—		$	10,841,844
Operating income (loss)	$	1,022,082	$	168,488	$	114,907	$	(4,907,557	)	$	(3,602,080	)

(17) Discontinued Operations

CPM ASC and PainCare Surgery Centers, Inc. are allocated in the ancillary operating segment. HCCT, ALO, CPM, GPP and TCC are allocated in the Pain Management operating segment. The results of the discontinued operations of HCCT, ALO, GPP, CPM, CPM ASC, TCC and the PainCare Surgery Centers, Inc, businesses, included in the accompanying consolidated statements of operations for the six months ended June 30, 2007 were as follows:


	2007
	GPP			HCCT			ALO			CPM			CPM ASC			TCC			PCSI			Adjustments			Total
Net Revenue	$	1,307,078		$	888,679		$	335,248		$	3,968,950		$	2,420,667		$	371,347		$	4,347,089		$	—		$	13,639,058
Cost of revenue and operating expenses		1,507,170			1,308,246			356,880			2,335,209			1,421,481			398,455			8,371,882			587,550			16,286,873
Operating income (loss)		(200,092	)		(419,567	)		(21,632	)		1,633,741			999,186			(27,108	)		(4,024,793	)		(587,550	)		(2,647,815	)
Interest (expense)		(215	)		(414	)		—			(262	)		—			(177	)		(3,344	)		(2,839,158	)		(2,843,570	)
Other income (expense)		1,340			—			353			—			—			—			19,869			—			21,562
Income (expense) before provision for income taxes and minority interest		(198,967	)		(419,981	)		(21,279	)		1,633,479			999,186			(27,285	)		(4,008,268	)		(3,426,708	)		(5,469,823	)
Provision (benefit) for income taxes								10,129															—			10,129
Income (loss) before minority interest		(198,967	)		(419,981	)		(31,408	)		1,633,479			999,186			(27,285	)		(4,008,268	)		(3,426,708	)		(5,479,952	)
Minority interest in earnings of discontinued operations		—			—			—			—			—			—			851,077			—			851,077

Income from discontinued operations		(198,967	)		(419,981	)		(31,408	)		1,633,479			999,186			(27,285	)		(4,859,345	)		(3,426,708	)		(6,331,029	)
Loss from disposal of discontinued operations		533,682			842,387			6,400,169			18,357,081			5,099,615			368,712			—			—			31,601,646

Total income (loss) from discontinued operations	$	(732,649	)	$	(1,262,368	)	$	(6,431,577	)	$	(16,723,602	)	$	(4,100,429	)	$	(395,997	)	$	(4,859,345	)	$	(3,426,708	)	$	(37,932,675	)

CPM ASC and PainCare Surgery Centers, Inc. are allocated in the ancillary operating segment. HCCT, ALO, CPM, and GPP are allocated in the Pain Management operating segment. The results of the discontinued operations of HCCT, ALO, GPP, CPM, CPM ASC, and the PainCare Surgery Centers, Inc, businesses, included in the accompanying consolidated statements of operations for the three months ended June 30, 2007 were as follows:


	2007
	GPP			HCCT			ALO			CPM			CPM ASC			PCSI			Adjustments			Total
Net Revenue	$	289,994		$	251,342		$	116,013		$	1,367,984		$	891,227		$	2,065,575		$	—		$	4,982,135
Cost of revenue and operating expenses		287,020			274,816			130,974			971,189			471,844			7,242,745			587,550			9,966,138
Operating income (loss)		2,974			(23,474	)		(14,961	)		396,795			419,383			(5,177,170	)		(587,550	)		(4,984,003	)
Interest (expense)		—			(414	)		—			—						(203	)		(1,391,111	)		(1,391,728	)
Other income (expense)		—			—			—			—						14,275			—			14,275
Income (loss) before provision for income taxes and minority interest		2,974			(23,888	)		(14,961	)		396,795			419,383			(5,163,098	)		(1,978,661	)		(6,361,456	)
Benefit (provision) for income taxes		(61,849	)		(125,286	)		(3,595	)		421,376			190,806			(231,397	)		(134,552	)		55,503
Income (loss) before minority interest		(58,875	)		(149,174	)		(18,556	)		818,171			610,189			(5,394,495	)		(2,113,213	)		(6,305,953	)
Minority interest in earnings of discontinued operations		—			—			—			—			—			528,234			—			528,234

Income from discontinued operations		(58,875	)		(149,174	)		(18,556	)		818,171			610,189			(5,922,729	)		(2,113,213	)		(6,834,187	)
Loss from disposal of discontinued operations, net of tax		533,682			842,387			6,400,169			18,357,081			5,099,615			—			—			31,232,934

Total income (loss) from discontinued operations	$	(592,557	)	$	(991,561	)	$	(6,418,725	)	$	(17,538,910	)	$	(4,489,426	)	$	(5,922,729	)	$	(2,113,213	)	$	(38,067,121	)

Physiom, CPM ASC and PainCare Surgery Centers, Inc. are allocated in the ancillary operating segment. HCCT, ALO, CPM, GPP and TCC are allocated in the Pain Management operating segment. The results of the discontinued operations of HCCT, ALO, GPP, CPM, CPM ASC, TCC, Physiom and the PainCare Surgery Centers, Inc, businesses, included in the accompanying consolidated statements of operations for the six months ended June 30, 2006 were as follows:


	2006
	HCCT			ALO		GPP			CPM		CPM ASC		TCC			PCSI			Physiom		Adjustments			Total
Net Revenue	$	1,553,789		$	1,175,973	$	2,946,568		$	5,584,570	$	2,991,125	$	2,114,266		$	5,377,494		$	2,167,549	$	—		$	23,911,334
Cost of revenue and operating expenses		931,163			633,375		2,634,086			3,083,727		1,985,060		1,014,007			2,807,405			908,642		—			13,997,465

Operating income (loss)		622,626			542,598		312,482			2,500,843		1,006,065		1,100,259			2,570,089			1,258,907		—			9,913,869
Interest (expense)		(670	)		—		(855	)		102		—		(4,375	)		(7,006	)		—		(1,977,111	)		(1,989,915	)
Other income (expense)		—			—		2,689			—		—		—			10,427			—		—			(13,116	)
Income (loss) before provision for income taxes and minority interest		621,956			542,598		314,316			2,500,945		1,006,065		1,095,884			2,573,510			1,258,907		(1,977,111	)		7,937,070
Provision income taxes		231,079			202,894		121,274			850,840		411,282		374,133			613,637			428,752		—			3,233,891
Income (loss) before minority interest		390,877			339,704		193,042			1,650,105		594,783		721,751			1,959,873			830,155		(1,977,111	)		4,703,179
Minority interest in earnings of discontinued operations		—			—		—			—		—		—			770,339			—		—			770,339

Income from discontinued operations		390,877			339,704		193,042			1,650,105		594,783		721,751			1,189,534			830,155		(1,977,111	)		3,932,840
Loss from disposal of discontinued operations, net of tax		—			—		—			—		—		—			—			—		—			—

Total income (loss) from discontinued operations	$	390,877		$	339,704	$	193,042		$	1,650,105	$	594,783	$	721,751		$	1,189,534		$	830,155	$	(1,977,111	)	$	3,932,840


	2006
	Physiom			TCC			GPP			ALO		HCCT			CPM			CPM ASC			PCSI			Adjustments			Total
Net Revenue	$	1,383,723		$	962,897		$	1,518,316		$	479,499	$	691,966		$	2,839,397		$	1,629,615		$	3,244,054		$	—		$	12,749,467
Cost of revenue and operating expenses		421,107			536,166			1,435,699			254,353		459,462			1,544,847			1,018,587			1,499,071			—			7,169,292

Operating income (loss)		962,616			426,731			82,617			225,146		232,504			1,294,550			611,028			1,744,983			—			5,580,175
Interest (expense)		—			—			(415	)		—		—			—			—			(4,571	)		(666,387	)		(671,373	)
Other income (expense)		—			(3,872	)		476			—		(670	)		(33	)		—			1,688			—			(2,411	)
Income (loss) before provision for income taxes and minority interest		962,616			422,859			82,678			225,146		231,834			1,294,517			611,028			1,742,100			(666,387	)		4,906,391
Provision (benefit) for income taxes		328,013			145,304			43,560			94,961		98,210			809,824			(52,775	)		445,068			—			1,912,165
Income (loss) before minority interest		634,603			277,555			39,118			130,185		133,624			484,693			663,803			1,297,032			(666,387	)		2,994,226
Minority interest in earnings of discontinued operations		(118,516	)		—			—			—		—			—			—			514,985			—			396,469

Income from discontinued operations		753,119			277,555			39,118			130,185		133,624			484,693			663,803			782,047			(666,387	)		2,597,757
Loss from disposal of discontinued operations, net of tax		—			—			—			—		—			—			—			—			—			—

Total income (loss) from discontinued operations	$	753,119		$	277,555		$	39,118		$	130,185	$	133,624		$	484,693		$	663,803		$	782,047		$	(666,387	)	$	2,597,757

(a)	Adjustments include $587,500 in disposition costs for the six months ended June 30, 2007. Interest was allocated at $2,839,158 and $1,977,111 for the six months and three months ended June 30, 2007 respectively.

The assets and liabilities of the TCC, GPP, ALO, HCCT, CPM, CPM ASC and PainCare Surgery Centers, Inc. businesses included in the consolidated balance sheets as of June 30, 2007 and December 31, 2006 were as follows:


	June 30, 2007 (unaudited)		December 31, 2006
Assets
Cash	$	226,206	$	1,292,159
Accounts receivable		6,045,560		10,402,272
Deposits and prepaids		378,376		776,364
Deferred taxes		—		96,235

Current assets of discontinued operations		6,650,142		12,567,030

Property and equipment, net		830,862		2,156,871
Goodwill		8,792,320		58,951,126
Other assets		404,473		1,023,634
Non-current deferred tax asset		1,529,561		852,341

Non-current assets of discontinued operations		11,557,216		62,983,972

Total assets of discontinued operations	$	18,207,358	$	75,551,002

Liabilities
Accounts payable and accrued liabilities	$	236,939	$	1,961,848
Current portion of capital lease obligations		—		18,367
Current portion of notes payable		—		62,000
Deferred taxes, current		1,529,561		—

Current liabilities of discontinued operations		1,766,500		2,042,215
Capital lease obligations		—		46,859
Deferred taxes		—		218,109

Long term liabilities of discontinued operations		—		264,968

Total liabilities of discontinued operations	$	1,766,500	$	2,307,183

Minority interest in discontinued operations		2,904,605		2,191,797
Book value of net assets	$	13,536,253	$	71,052,022

On February 28, 2007, the PainCare Holdings Inc. parties and Centeno Shultz, Inc. entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets of the PainCare Sub for purchase price of the lesser of $250,000 or the total amount of proceeds generated from the sale of certain shares of common stock of PainCare ( the “PainCare Shares”) issued to the Centeno Parties in the Purchase Transaction, and (ii) in exchange for the PainCare parties to terminate the Management Agreement and any and all other agreements between CSI and the PainCare Parties, CSI paid the PainCare Parties $750,000 plus all remaining proceeds in excess of $250,000 from the sale of the PainCare shares. In connection with the termination of the Management Agreement, CSI entered into a promissory note with a principal balance of $375,000 with imputed interest of 8.25% payable by June 1, 2008.

The discontinued operations of the PainCare Surgery Centers, Inc. were allocated interest because the Company is required by our senior lender HBK Investments to repay their note upon the sale of PainCare Surgery Centers, Inc. As a result, interest expense of $2,839,158 and $1,977,111, respectively, has been included in the results of the discontinued operations recorded as held for sale.

The following table shows the components of the loss from sale of Centeno Shultz, Inc.(TCC), net of taxes as of February 28, 2007:


Proceeds	$	1,419,302
Book value of net assets disposed		(1,769,108	)
Cost of disposition		(18,906	)

Loss on sale of discontinued operations	$	(368,712	)
Income tax benefit, net of valuation allowance of $134,551		—

Loss on sale of discontinued operations, net	$	(368,712	)

On April 30, 2007, the PainCare Holdings Inc. parties and Georgia Pain Physicians, PC, (“GPP”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $125,000. $50,000 is due at closing and the remaining balance is a $75,000 promissory note payable in three consecutive installments of $25,000 a month starting June 1, 2007 and paid in full no later than August 1, 2007. Due to the immaterial nature, interest is not imputed on this note.

The following table shows the components of the loss from sale of Georgia Pain Physicians, PC net of taxes as of April 30, 2007:


Proceeds	$	125,000
Book value of net assets disposed		(658,682	)

Loss on sale of discontinued operations	$	(533,682	)
Income tax benefit, net of valuation allowance of $53,655		—

Loss on sale of discontinued operations, net	$	(533,682	)

rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $200,000, due at closing, along with a promissory note in the amount of $200,000 to be repaid with $7,060 of interest in six consecutive installments of $34,510 beginning on June 15, 2007. As of June 30, 2007, the PainCare, Inc. parties have received $34,510 in cash payments for the sale of the PainCare Sub leaving a remaining balance on the note in the amount of $167,490.

The following table shows the components of the loss from sale of Alo, M.D., P.A., net of taxes as of May 21, 2007:


Proceeds	$	400,000
Book value of net assets disposed		(6,800,169	)

Loss on sale of discontinued operations	$	(6,400,169	)
Income tax benefit permanent difference, not applicable		—

Loss on sale of discontinued operations, net	$	(6,400,169	)

On May 22, 2007, PainCare, PainCare Sub, and HealthCare Center of Tampa, (“HCCT”), entered into a Settlement Agreement and several ancillary documents, pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $440,000 at closing and agreed to remit the proceeds from the sale of his 685,000 shares of common stock in PainCare Holdings Inc. HCCT purchased from PainCare and PainCare Sub certain medical equipment for a purchase price of $35,000.

The following table shows the components of the loss from sale of The HealthCare Center of Tampa, net of taxes as of May 22, 2007:


Proceeds	$	570,428
Book value of net assets disposed		(1,412,815	)

Loss on sale of discontinued operations	$	(842,387	)
Income tax benefit, net of valuation allowance of $124,039		—

Loss on sale of discontinued operations, net	$	(842,387	)

The following table shows the components of the loss from sale of The Center for Pain Management ASC, LLC, net of taxes as of May 21, 2007:


Proceeds	$	7,860,094
Book value of net assets disposed		(12,959,709	)

Loss on sale of discontinued operations		(5,099,615	)
Income tax benefit, net of valuation allowance of $3,920,441		—

Loss on sale of discontinued operations, net	$	(5,099,615	)

The following table shows the components of the loss from sale of The Center for Pain Management, LLC, net of taxes as of May 21, 2007:


Proceeds	$	7,376,739
Book value of net assets disposed		(25,733,820	)

Loss on sale of discontinued operations		(18,357,081	)
Income tax benefit, net of valuation allowance of $5,684,872		—

Loss on sale of discontinued operations, net	$	(18,357,081	)

(17) Subsequent Events

Coral Gables Surgical Center

On August 3, 2007, Surgery Partners Holdings, LLC, a Florida limited liability company (“Surgery Partners”), Surgery Partners of Coral Gables, LLC, a Florida limited liability company (“SPCG,” and together with Surgery Partners, the “Purchaser”), and PainCare Surgery Centers II, Inc. (the “Seller”), a Florida corporation and subsidiary of PainCare Holdings, Inc. (the “Company”), entered into a Partnership Interest Purchase Agreement (the “Purchase Agreement”) and several ancillary documents pursuant to which Seller agreed to sell to Purchaser its 63.09% of the partnership interests (the “Partnership Interests”) of PSHS Beta Partners, Ltd., d/b/a the Gables Surgery Center (the “Gable ASC”), which operates a free standing, multi-specialty, Florida licensed and Medicare certified ambulatory surgery center located in Coral Gables, Florida. The purchase price for the Partnership Interests is $4,105,319. Purchaser has deposited in escrow a total of $4,624,933, which amount includes the purchase price plus certain transaction related expenses and payments. The closing of the transactions set forth in the Purchase Agreement are subject to customary conditions, including, but not limited to, receipt by Purchaser of a license from the Florida Agency for Health Care Administration to operate the Gables ASC. Upon the closing of the transactions set forth in the Purchase Agreement, the effective date of the sale shall be the date the Purchase Agreement was executed. During the period of time between the execution of the Purchase Agreement and the closing, all financial and economic benefits of the Partnership Interests shall accrue to Purchaser, including, but not limited, to, the recognition of profits and losses attributed to the Partnership Interests and the right to receive the revenues and cash flows associated therewith. The Purchase Agreement may be terminated by either party if the transactions set forth therein are not closed on or before September 3, 2007.

Piedmont Center for Spinal Disorders

On July 31, 2007, PainCare Holdings, Inc. and Dr. Larry Cohen entered into a settlement agreement (the “Cohen Settlement Agreement”) and a series of ancillary documents pursuant to which the parties severed completely the relationship between the Company and Piedmont Center for Spinal Disorders in the following manner: (i) PainCare Acquisition Company XVIII sold to Dr. Cohen certain non-medical assets for a purchase price of $152,000 plus the total amount of proceeds generated from the sale of 80,000 shares of common stock of the Company owned by Dr. Cohen; (ii) PainCare Acquisition Company XVIII and Dr. Cohen terminated the Management Services Agreement and any and all other agreements between the parties; and (iii) the parties entered into general release agreements.

LakeWorth Surgical Center

On July 13, 2007, Surgery Partners Holdings, LLC, a Florida limited liability company (“Surgery Partners”), Surgery Partners of Lake Worth, LLC, a Florida limited liability company (“SPLW,” and together with Surgery Partners, the “Purchaser”), and PainCare Surgery Centers I, Inc. (the “Seller”), a Florida corporation and subsidiary of PainCare Holdings, Inc. (the “Company”), entered into a Partnership Interest Purchase Agreement (the “Purchase Agreement”) and several ancillary documents pursuant to which Seller sold to Purchaser its 58.5% of the partnership interests (the “Partnership Interests”) of PSHS Alpha Partners, Ltd., d/b/a the Lake Worth Surgery Center (the “Lake Worth ASC”), which operates a free standing, multi-specialty, Florida licensed and Medicare certified ambulatory surgery center located in Lake Worth, Florida. The purchase price consists of $10 million cash at closing with potential additional earn-out payments of up to a total of $2.3 million cash over 5 years based upon the amount of certain cash collections by the Lake Worth ASC over the same 5 year period. The closing of the transactions set forth in the Purchase Agreement are subject to customary conditions, including, but not limited to, receipt by Purchaser of a license from the Florida Agency for Health Care Administration to operate the Lake Worth ASC. Upon the closing of the transactions set forth in the Purchase Agreement, the effective date of the sale shall be the date the Purchase Agreement was executed. During the period of time between the execution of the Purchase Agreement and the closing, all financial and economic benefits of the Partnership Interests shall accrue to Purchaser, including, but not limited, to, the recognition of profits and losses attributed to the Partnership Interests and the right to receive the revenues and cash flows associated therewith. On August 13, 2007 the conditions to closing contained in the Purchase Agreement were met.

Rocky Mountain Pain Center

On July 27, 2007, PainCare Holdings, Inc. (“the Company”) and Dr. Floyd Ring entered into a settlement agreement (the “Ring Settlement Agreement”) and a series of ancillary documents pursuant to which the parties severed completely the relationship between the Company and Rocky Mountain Pain Consultants in the following manner: (i) PainCare Acquisition Company XXIII sold to Dr. Ring certain non-medical assets for a purchase price of $300,000, subject to adjustment, plus the total amount of proceeds generated from the sale of 488,064 shares of common stock of PainCare owned by Dr. Ring; (ii) PainCare Acquisition Company XXIII and Dr. Ring terminated the Management Service Agreement and any and all other agreements between the parties; and (iii) the parties entered into general release agreements.

ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide the reader with information that will assist in understanding our consolidated financial statements, the changes in certain key items in those financial statements from year to year, and the primary factors that accounted for those changes, as well as how certain accounting principles affect our consolidated financial statements. The discussion also provides information about the financial results of the various segments of our business to provide a better understanding of how those segments and their results affect the financial condition and results of operations of PainCare as a whole.

Cautionary Statement Regarding Forward-Looking Statements

The terms “PainCare,” “Company,” “we,” “our,” and “us” refer to PainCare Holdings, Inc. and its consolidated subsidiaries unless the context suggests otherwise.

This quarterly report contains and may incorporate by reference “forward-looking” statements, including statements regarding our expectations, beliefs, intentions or strategies regarding the future. Such statements can be identified by the use of forward-looking terminology such as “may,” “will,” “believe,” “intend,” “expect,” “anticipate,” “estimate,” “continue,” or other similar words. Variations on those or similar words, or the negatives of such words, also may indicate forward-looking statements.

These forward-looking statements, which may include statements regarding our future financial performance or results of operations, including expected revenue growth, cash flow growth, future expenses, future operating margins and other future or expected performance, are subject to the following risks:

•

the acquisition of businesses or the launch of new lines of business, which could increase operating expenses and dilute operating margins;

•

the inability to attract new patients by our owned practices, the managed practices and the limited management practices;

•

increased competition, which could lead to negative pressure on our pricing and the need for increased marketing;

•

the inability to maintain, establish or renew relationships with physician practices, whether due to competition or other factors;

•

the inability to comply with regulatory requirements governing our owned practices, the managed practices and the limited management practices;

•

that projected operating efficiencies will not be achieved due to implementation difficulties or contractual spending commitments that cannot be reduced;

•

current cash on hand will be inadequate to fund daily operations; and

•

general risks associated with our businesses.

In addition to the risks and uncertainties discussed above you can find additional information concerning risks and uncertainties that would cause actual results to differ materially from those projected or suggested in the forward-looking statements in our annual report on Form 10-K for the year ended December 31, 2006, under the section “Risk Factors.” The forward-looking statements contained in this quarterly report represent our judgment as of the date of this quarterly report, and you should not unduly rely on such statements.

Outlook

PainCare is a provider of pain-focused medical and surgical solutions. Through our proprietary network of acquired or managed physician practices, and in partnership with independent physician practices and medical institutions throughout the United States and Canada, PainCare is committed to utilizing the most advanced science and technologies to diagnose and treat pain stemming from neurological and musculoskeletal conditions and disorders.

Our business is currently divided into four primary operating divisions; pain management, surgery, ancillary services and a fourth that manages certain other revenue producing activities and corporate functions. These four segments correspond to our four reporting segments discussed later in this Item.

Although our business is continuing to generate revenues, and market factors appear to favor our pain management and ancillary service business models, we still have several immediate internal and external challenges to overcome before we can realize significant improvements in our business, including:

•

Operational Improvements. We are in the process of improving our operational efficiency within all segments. This includes streamlining our operational structure, implementing standardized accounting procedures, and ensuring high quality patient care. We also strive to reduce operational variation across all segments.

•

Continuing Litigation. We are party to class action lawsuits which will require management attention and company resources until settlements are reached.

•

Medical Reimbursement Rates. Congress and some state legislatures have proposed significant changes in the health care system. Many of these changes have the potential to result in limitations on and, in some cases, significant reductions in the levels of, reimbursement rates to health care providers for services under many government reimbursement programs.

•

Restatement and Sarbanes-Oxley Related Costs. We paid approximately $2.4 million in 2006 in connection with the restatement of our consolidated financial statements for the years ended December 31, 2004, 2003, 2002, 2001 and 2000, and internal controls over financial reporting. We anticipate incurring SOX related costs in the future, but at a significant cost reduction.

While we expect our 2007 operating results will be consistent with the fact that we are still in a turnaround period, we are optimistic about the long-term positioning of PainCare. We continue to offer high quality services in growing segments of the health care industry which should provide long-term growing opportunities. In addition, we are stabilizing operations across all of our operating segments by focusing on volume growth, expense control through cash management initiatives and centralizing the accounting processes.

Results of Operations

During the six months ended June 30, 2007 and 2006, we derived consolidated Net operating revenues from the following payor sources:


	Six Months Ended June 30,
	2007		2006
			(as restated)
Government	$	5,245,374	$	5,657,243
Private Ins.		9,948,261		10,468,560
Personal Injury		2,212,901		2,502,583
Self-pay		399,833		515,667
Workers’ compensation		1,782,045		2,984,614
Other		355,975		859,785

Total	$	19,944,389	$	22,988,452

During the three months ended June 30, 2007 and 2006, we derived consolidated Net operating revenues from the following payor sources:


	Three Months Ended June 30,
	2007		2006
			(as restated)
Government	$	2,537,737	$	2,439,515
Private Ins.		4,443,434		5,134,248
Personal Injury		1,344,740		1,585,248
Self-pay		289,364		306,002
Workers’ compensation		836,655		917,694
Other		124,436		459,137

Total	$	9,576,366	$	10,841,844

When reading our condensed consolidated statements of operations, it is important to recognize the following items included within our results of operations:

Impairments. The Company continually evaluates the performance of the individual practices. Any practice that is deemed to be underperforming will become subject to more direct oversight by our management team. To the extent, additional oversight fails to improve the practice’s performance over a period of time, the practice will become subject to additional company imposed actions, but not limited to, potential restructuring or divestiture. Due to this analysis, the company took an additional $3,969,417 charge to Associated Physicians Group, $5,825,796 charge to Colorado Pain Specialist, $2,452,790 charge to Piedmont Center for Spinal Disorders, and $2,828,944 charge to Rocky Mountain Pain Center.

Disposal of business units. The Company entered into and signed a rescission agreement with Centeno Shultz, Inc. on February 28, 2007, Georgia Pain Physicians, PC on April 30, 2007, Kenneth Alo, M.D., P.S. on May 21, 2007, Center for Pain Management ASC, LLC on May 21, 2007, Center for Pain Management, LLC on May 21, 2007, and Health Care Center of Tampa on May 22, 2007. At June 30, 2007, all consolidated transactional information pertaining to the above mentioned disposals have been classified as loss on disposal.

Assets held for sale. With The Company’s decision to sell three ambulatory surgical centers, (“ASC’s”) separately, Center for Pain Management ASC sold during the second quarter leaving Lake Worth Surgical Center and the Gables Surgery Center as held for sale. Subsequent to the quarter end, the Company entered into purchase contracts for the sale of the Lake Worth Surgery Center and the Gables Surgery Center on July 13, 2007 and August 3, 2007, respectively.

For the six months ended June 30, 2007 and 2006, our consolidated results of operations were as follows:

Operating Expenses as a % of Net Operating Revenues


	Six Months Ended June 30,
	2007			% of Revenues		2006			% of Revenues		% Change 2007 vs. 2006
Net operating revenues from continuing operations	$	19,944,389				$	22,988,452
Operating expenses from continuing operations:
Salaries/benefits, bonuses, taxes		14,580,510		73.1	%		12,192,740		53.0	%	19.6	%
Professional fees		3,945,227		19.8	%		4,463,015		19.4	%	-11.6	%
Supplies		1,334,723		6.7	%		1,404,619		6.1	%	-4.9	%
Equity compensation		130,100		0.7	%		(8,068,538	)	-35.1	%	-101.6	%
Marketing and Advertising		629,051		3.2	%		646,545		2.8	%	-2.7	%
Depreciation		901,478		4.5	%		838,405		3.6	%	7.5	%
Amortization		222,600		1.1	%		1,006,957		4.4	%	-77.9	%
Impairment of goodwill		15,076,947		75.6	%		—		—
Impairment of other assets		148,127		0.7	%		—		—
Other operating expenses		6,036,755		30.3	%		4,729,927		20.6	%	27.6	%

Total operating expenses		43,005,518					17,213,670

Operating income (loss)		(23,061,129	)				5,774,782

Income (loss) from continuing operations before income tax benefit (expense)		(26,348,712	)				14,670,154
Income tax benefit (expense)		1,886,453					(1,927,304	)
Gain (loss) from discontinued operations, net of tax		(37,932,675	)				3,932,840
Cumulative change of accounting principle, net of tax		—					991,925

Net income (loss)	$	(62,394,934	)			$	17,667,615

*	Other operating expenses were cutoff at any single category under 2% of total operating expenses, other than Equity Compensation, Amortization, Impairment, and of other assets.

For the three months ended June 30, 2007 and 2006, our consolidated results of operations were as follows:

Operating Expenses as a % of Net Operating Revenues


	Three Months Ended June 30,
	2007			% of Revenues		2006			% of Revenues		% Change 2007 vs. 2006
Net operating revenues from continuing operations	$	9,576,366				$	10,841,844
Operating expenses from continuing operations:
Salaries/benefits, bonuses, taxes		7,576,866		79.1	%		6,410,252		59.1	%	18.2	%
Professional fees		1,452,589		15.2	%		3,055,370		28.2	%	-52.5	%
Supplies		644,710		6.7	%		765,806		7.1	%	-15.8	%
Equity compensation		63,866		0.7	%		513,836		4.7	%	-87.6	%
Marketing and Advertising		289,373		3.0	%		382,230		3.5	%	-24.3	%
Depreciation		473,911		4.9	%		401,812		3.7	%	17.9	%
Amortization		191,017		2.0	%		564,045		5.2	%	-66.1	%
Impairment of goodwill		15,076,947		157.4	%		—		0.0	%
Impairment of other assets		148,127		1.5	%		—		0.0	%
Other operating expenses		3,383,416		35.3	%		2,350,573		21.7	%	43.9	%

Total operating expenses		29,300,822					14,443,924

Operating income (loss)		(19,724,456	)				(3,602,080	)

Income (loss) from continuing operations before income tax benefit (expense)		(21,299,372	)				(4,614,193	)
Income tax benefit		146,655					1,466,685
Gain (loss) from discontinued operations, net of tax		(38,067,121	)				2,597,757
Cumulative change of accounting principle, net of tax		—					—

Net income (loss)	$	(59,219,838	)			$	(549,751	)

*	Other operating expenses were cutoff at any single category under 2% of total operating expenses, other than Equity Compensation and Impairment of other assets.

Net operating Revenues

Our consolidated net operating revenues primarily include revenues from patient care services provided by one of the three primary operating segments as well as revenue derived from management and real estate services provided through corporate headquarters.

During the three and six months ended June 30, 2007, net operating revenues from continuing operations decreased by approximately $3.0 million from 2006 to 2007. This decrease relates primarily to decreased volume and reimbursement at three practices in particular.

Salaries, wages and benefits

Salaries, wages, and benefits represent the most significant expense and include all amounts paid to full and part-time employees, including all related costs of benefits and bonuses provided to employees. It also includes amounts paid for contract labor.

During the three and six months ended June 30, 2007, salaries, wages, and benefits increased by $.9 and $2.3 million, respectively, from 2006 to 2007. This increase was due primarily to additional compensation paid to providers including payments made to physicians subsequent to the end of that shareholder’s earnout period as well as additional providers added to increase volume prospectively. Compensation also increased at the corporate headquarters for specialized personnel with legal and financial/accounting backgrounds to reduce the costs of reliance on third party providers and consultants. Expenses have also been increased for the development of Integrated Pain Solutions.

Professional fees

Professional fees include those fees associated with outside contractors performing professional development services. Professional fees also include professional consulting fees associated with operational functions such as Sarbanes-Oxley compliance and certain legal and accounting fees.

During the three and six months ended June 30, 2007, professional fees decreased by $1.6 and $.5 million, respectively, from 2006 to 2007. The decrease related to the expenses in 2006 associated with restatement of prior years financial statements, Sarbanes Oxley costs and litigation related costs.

Other operating expenses

Other operating expenses include costs associated with managing and maintaining our operating facilities as well as the general and administrative costs related to the operations of our corporate office. These expenses include such items as repairs and maintenance, utilities, contract services, rent, and insurance among others.

For the three and six months ended June 30, 2007 other operating expenses increased by $.8 and $1.3 million, respectively from 2006 to 2007. This increase is primarily related to occupancy costs and other expenses associated with efforts to expand pre-existing practice operations. The other significant cost in this category is for liquidated damages associated with the 2006 PIPE placement of $430,000 in the six months ended June 30, 2007.

Depreciation and amortization

Depreciation and amortization is the monthly and quarterly estimated charge to fixed and intangible assets which accounts for the amount of the useful life used. Such fixed assets include property, plant and equipment, medical equipment and office equipment.

During the three and six months ended June 30, 2007, depreciation and amortization decreased by $.3 and $.7 million. This decrease is due to the fact that amortization of contract rights for one substantial practice was completed in 2006.

Derivative expense (income)

The existence of derivative expense/income is directly related to the Company’s convertible debentures. The recording of derivative expense/income has an inverse relationship to the company’s stock price. As the Company’s stock price increases, our derivative expense increases and as our stock price decreases our derivative expense becomes derivative income. During 2006, derivative income of $10.0 million was recorded. The derivatives resulted in no income or expense during the six months ended June 30, 2007. (See Footnote 13)

Impairment of goodwill

The expenses associated with the impairment of goodwill relate specifically to four physician practices. The expected future cash flows from the practices no longer support the level of goodwill previously reported. The $15 million charge reflects the best estimate of fair value of these entities.

Stock Compensation Plans

The Company recorded stock based compensation under SFAS 123(R) as a liability plan from January 1, 2006 to May 4, 2006. Additionally, on May 25, 2006, the Company also made a material modification to three officers options awards as they became fully vested on that date.

The accounting treatment through May 4, 2006 caused the recognition of a significant financial statement benefit. A benefit of $.7 and $9.2 million was recorded in the three and six months ended June 30, 2006. These amounts were offset by a $1.1 million expense to account for the fully vested options.

Upon conversion of the plan to equity treatment, the amounts recorded are insignificant in comparison to the impact of the liability plan in prior years.

Consolidated Adjusted EBITDA

Management believes that understanding Consolidated Adjusted EBITDA is important in measuring operating performance, leverage capacity, ability to service debt, and make capital expenditures.

In general terms, the definition of Consolidated Adjusted EBITDA, per our credit agreement, is defined as consolidated net earnings (or loss), minus extraordinary gains and interest income, plus interest expense, income taxes, and depreciation and amortization for such period, in each case, as determined in accordance with GAAP.

We use Consolidated Adjusted EBITDA on a consolidated basis to assess our operating performance. We believe it is meaningful because it provides investors a basis using criteria that are used by our internal decision makers. The Company’s internal decision makers believe Consolidated Adjusted EBITDA is a meaningful measure, because it represents a transparent view of our ongoing operating performance and allows management to readily view operating trends, perform analytical comparisons and benchmarking

between segments. While consolidated EBITDA is a meaningful measure, management believes the inclusion of professional fees associated with litigation, accounting restatement, audit and tax work associated with the restatement process, and the implementation of Sarbanes-Oxley Section 404 and other non-ordinary course charges within EBITDA the ability to efficiently assess and view the core operating trends on a consolidated basis and within segments.

We also use Consolidated Adjusted EBITDA on a consolidated basis as a liquidity measure. We believe this financial measure on a consolidated basis is important in analyzing our liquidity because it is also a component of certain material covenants contained within and defined by our credit agreement. These covenants are material terms of these agreements because they govern our credit agreement, which in turn represent a substantial portion of our capitalization. Non-compliance with these financial covenants under our credit facilities—our interest coverage ratio and our leverage ratio—could result in the lenders requiring us to immediately repay all amounts borrowed. Any such acceleration could also lead the investors in our public debt to accelerate their maturity. In addition, if we cannot satisfy these financial covenants in the indenture governing the credit agreements, we cannot engage in certain activities, such as incurring additional indebtedness, making certain payments, acquiring and disposing of assets. Consequently, Consolidated Adjusted EBITDA is critical to our assessment of our liquidity.

However, Consolidated Adjusted EBITDA is not a measure of financial performance under generally accepted accounting principles in the United States of America, and the items excluded from Consolidated Adjusted EBITDA are significant components in understanding and assessing financial performance. Therefore, Consolidated Adjusted EBITDA should not be considered a substitute for net gain/(loss) from continuing operations or cash flows from operating, investing, or financing activities. Because Consolidated Adjusted EBITDA is not a measurement determined in accordance with generally accepted accounting principles in the United States of America and is thus susceptible to varying calculations, Consolidated Adjusted EBITDA, as presented, may not be comparable to other similarly titled measures of other companies. Therefore consolidated adjusted EBITDA is reconciled to net cash (used in) provided by operating activities. Revenue and expenses are measured in accordance with the policies and procedures described in Note 1, Summary of Significant Accounting Policies, to our accompanying consolidated financial statements.

Our Consolidated Adjusted EBITDA for the six months ended June 30, 2007 and 2006 was as follows:

Reconciliation of Loss from Continuing Operations to Consolidated Adjusted EBITDA


	Six Months Ended June 30,
	2007			2006
Net Income (loss)	$	(62,394,934	)	$	17,667,615
Cumulative effect of a change in accounting principle, net of tax		—			(991,925	)
Income (loss) from discontinued operations, net of tax		37,932,675			(3,932,840	)

Loss from continuing operations	$	(24,462,259	)	$	12,742,850
Provision (benefit) for income tax expense		(1,886,453	)		1,927,304
Depreciation and amortization		1,124,078			1,845,362
Impairment of goodwill		15,076,947			—
Impairment of other assets		148,127			—
Interest expense (income)		3,277,368			2,063,920
Other income (expense)		(10,215	)		440,421

Consolidated Adjusted EBITDA before derivative income and non-cash compensation		(6,732,407	)		19,019,857
Derivative income		—			(10,492,951	)
Fair value of options issued to employees		130,100			(8,729,821	)

Consolidated Adjusted EBITDA after derivative income and non-cash compensation	$	(6,602,307	)	$	(202,915	)

Reconciliation of Consolidated Adjustment EBITDA to Net Cash Provided by (Used In) Operating Activities


	Six Months Ended June 30,
	2007			2006
Consolidated Adjusted EBITDA	$	(6,602,307	)	$	(202,915	)
Interest expense and amortization of debt and discount and fees		(3,277,368	)		(2,063,920	)
Other income (expense)		10,215			(440,421	)
Amortization of debt issue costs, debt discounts, and fees		499,599			1,330,064
Stock issued for interest payments		194,140			196,050
Current portion of income tax provision		1,886,453			(1,927,304	)
Loss on disposal of property and equipment		121,978			—
Other non-cash transactions		49,555			431,373
Change in operating assets and liabilities		3,048,173			2,571,075
Net cash used in operating activities attributed to discontinued operations		916,492			1,991,534

Net Cash Provided by (Used In) Operating Activities	$	(3,153,070	)	$	1,885,536

The minimum EBITDA requirement per the Company’s loan and security agreement with HBK for the three months ended June 30, 2006 and 2007 were $8,000,000 and $10,000,000, respectively.

Consolidated Adjusted EBITDA decreased $6,399,392 from June 30, 2006 to 2007. The change in consolidated adjusted EBITDA is predominantly due to the fact that the Company is in a restructuring phase, which is having a substantial impact on operational performances.

Segment Results of Operations

Our internal financial reporting and management structure is focused on the major types of services provided by PainCare. We currently provide various patient care services through three operating segments and certain other services through a fourth segment, which correspond to our four reporting business segments: (1) pain management, (2) surgery, (3) ancillary services, and (4) corporate and other. For additional information regarding our business segments, including a detailed description of the services we provide and financial data for each segment, please see Item 1, Business , and Item 7, Management’s Discussion and Analysis of Financial Condition and results of Operations , to our 2006 Form 10-K and Note 24, Segment Reporting, to our condensed consolidated financial statements included under Part I, Item 1, Financial Statements (Unaudited) , of this report. Future changes to this organization structure may result in changes to the reportable segments disclosed.

For the six months ended June 30, 2007 and 2006, our results of operations by segment were as follows:


	Six Months Ended June 30,
	2007			2006
Net operating revenues
Pain Management	$	12,276,948		$	12,339,476
Surgery		2,201,365			3,485,077
Ancillary Services		5,466,076			7,163,899
Corporate and Other		—			—
Operating Earning*
Pain Management		(7,992,802	)		2,101,817
Surgery		(3,273,170	)		794,602
Ancillary Services		(3,736,881	)		1,075,377
Corporate and Other		(8,058,276	)		1,802,986

For the three months ended June 30, 2007 and 2006, our results of operations by segment were as follows:


	Three Months Ended June 30,
	2007			2006
Net operating revenues
Pain Management	$	6,111,888		$	6,568,065
Surgery		859,172			1,604,047
Ancillary Services		2,605,306			2,669,732
Corporate and Other		—			—
Operating Earning*
Pain Management		(8,553,864	)		1,022,082
Surgery		(3,095,507	)		168,488
Ancillary Services		(4,609,032	)		114,907
Corporate and Other		(3,466,053	)		(4,907,557	)

*	Results of operations for each operating segment include divisional overhead, but exclude corporate overhead. All corporate overhead is included in our corporate and other segment. See note, 24, to the financial statements included in our 2006 Form 10-K for additional information.

Pain Management

For the six months ended June 30, 2007 and 2006, our pain management segment comprised approximately 61.6% and 53.6%, respectively, of consolidated net operating revenues.

Surgery

For the six months ended June 30, 2007 and 2006, our surgery segment comprised approximately 11% and 15.1%, respectively, of consolidated net operating revenues.

Ancillary Services

For the six months ended June 30, 2007 and 2006, our ancillary services comprised of approximately 27.4% and 31.2%, respectively, of consolidated net operating revenues.

Pain Management

For the three months ended June 30, 2007 and 2006, our pain management segment comprised approximately 63.8% and 60.6%, respectively, of consolidated net operating revenues.

Surgery

For the three months ended June 30, 2007 and 2006, our surgery segment comprised approximately 8.9% and 14.8%, respectively, of consolidated net operating revenues.

Ancillary Services

For the three months ended June 30, 2007 and 2006, our ancillary services comprised of approximately 27.2% and 24.6%, respectively, of consolidated net operating revenues.

Corporate and Other

The corporate and other segment is comprised of all corporate overhead which does not recognize any revenues.

Results of Discontinued Operations and Assets Held for Sale

PainCare Holdings, Inc., through its subsidiaries, provides healthcare services for the treatment of pain through physician practices and surgery centers in North America and Canada. PainCare’s surgery segment constitutes a component of the entity because the operations of and cash flows of the ancillary segment can be clearly distinguished, operationally and for financial reporting purposes, from the rest of the entity.

With the intention of narrowing our core business strategy and to reduce debt obligations, PainCare’s management decided during 2006 to exit the ambulatory surgical center acquisition strategy, and has since committed to a plan to sell our interests in our three ambulatory surgical centers (ASC’s). On May 21, 2007, The Center for Pain Management ASC, LLC (CPMASC) and PainCare Holdings, Inc. rescinded the purchase transaction. CPM ASC is considered a discontinued operation instead of available for sale. PainCare’s ASC’s are classified as held for sale and measured at the lower of their carrying amount or fair value less costs to sell. The operations and cash flows of these ASC’s will be eliminated from continuing operations as a result of the sale transaction, and PainCare will have no continuing involvement in the operations of the product group after it is sold. The scenario meets the requirements of FASB Statement No. 144 . Therefore PainCare will report the results of operations of the component, including any gain or loss, in discontinued operations.

In accordance with FASB Statement No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, the Company records impairment losses on long-lived assets held for sale when events and circumstances indicate that the assets might be impaired if the fair value less costs to sell of the assets are less than the carrying amount of those assets. During 2006, the Company developed a plan to sell our three ASC’s with the intention of using the proceeds to pay off debt obligations. The Company estimated the sales value, net of related costs to sell, at amounts derived from preliminary discussions with our investment bankers. Accordingly, the Company recorded an impairment loss of $5,795,984 in 2007 and $2,297,013 in 2006 attributed to two of the ASC’s. The impairment was based on the Company’s best estimate of the fair value of the ASC less costs to sell.


	2007
	GPP			HCCT			ALO			CPM			CPM ASC			TCC			PCSI			Adjustments			Total
Net Revenue	$	1,307,078		$	888,679		$	335,248		$	3,968,950		$	2,420,667		$	371,347		$	4,347,089		$	—		$	13,639,058
Cost of revenue and operating expenses		1,507,170			1,308,246			336,880			2,335,209			1,421,481			398,455			8,371,882			587,550			16,286,873
Operating income (loss)		(200,092	)		(419,567	)		(21,632	)		1,633,741			999,186			(27,108	)		(4,024,793	)		(587,550	)		(2,647,815	)
Interest (expense)		(215	)		(414	)		—			(262	)		—			(177	)		(3,344	)		(2,839,158	)		(2,843,570	)
Other income (expense)		1,340			—			353			—			—			—			19,869			—			21,562
Income (expense) before provision for income taxes and minority interest		(198,967	)		(419,981	)		(21,279	)		1,633,479			999,186			(27,285	)		(4,008,268	)		(3,426,708	)		(5,469,823	)
Provision (benefit) for income taxes								10,129															—			10,129
Income (loss) before minority interest		(198,967	)		(419,981	)		(31,408	)		1,663,479			999,186			(27,285	)		(4,008,345	)		(3,426,708	)		(5,479,952	)
Minority interest in earnings of discontinued operations		—			—			—			—			—			—			851,077			—			851,077

Income from discontinued operations		(198,967	)		(419,981	)		(31,408	)		1,663,479			999,186			27,285			(4,859,345	)		(3,426,708	)		(6,331,029	)
Loss from disposal of discontinued operations, net of tax		533,682			842,387			6,400,169			18,357,081			5,099,615			368,712			—			—			31,601,646

Total income (loss) from discontinued operations	$	(732,649	)	$	(1,262,368	)	$	(6,431,577	)	$	(16,723,602	)	$	(4,100,429	)	$	(395,997	)	$	(4,859,345	)	$	(3,426,708	)	$	(37,932,675	)


	2007
	GPP			HCCT			ALO			CPM			CPM ASC			PCSI			Adjustments			Total
Net Revenue	$	289,994		$	251,342		$	116,013		$	1,367,984		$	891,227		$	2,065,575		$	—		$	4,982,135
Cost of revenue and operating expenses		287,020			274,816			130,974			971,189			471,844			7,242,745			587,550			9,966,138
Operating income (loss)		2,974			(23,474	)		(14,961	)		396,795			419,383			(5,177,170	)		(587,550	)		(4,984,003	)
Interest (expense)		—			(414	)		—			—						(203	)		(1,391,111	)		(1,391,728	)
Other income (expense)		—			—			—			—						14,275			—			14,275
Income (loss) before provision for income taxes and minority interest		2,974			(23,888	)		(14,961	)		396,795			419,383			(5,163,098	)		(1,978,661	)		(6,361,456	)
Benefit (provision) for income taxes		(61,849	)		(125,286	)		(3,595	)		421,376			190,806			(231,397	)		(134,552	)		55,503
Income (loss) before minority interest		(58,875	)		(149,174	)		(18,556	)		818,171			610,189			(5,394,495	)		(2,113,213	)		(6,305,953	)
Minority interest in earnings of discontinued operations		—			—			—			—			—			528,234			—			528,234

Income from discontinued operations		(58,875	)		(149,174	)		(18,556	)		818,171			610,189			(5,922,729	)		(2,113,213	)		(6,834,187	)
Loss from disposal of discontinued operations, net of tax		533,682			842,387			6,400,169			18,357,081			5,099,615			—			—			31,232,934

Total income (loss) from discontinued operations	$	(592,557	)	$	(991,561	)	$	(6,418,725	)	$	(17,538,910	)	$	(4,489,426	)	$	(5,922,729	)	$	(2,113,213	)	$	(38,067,121	)


	2006
	HCCT			ALO		GPP			CPM		CPM ASC		TCC			PCSI			Physiom		Adjustments			Total
Net Revenue	$	1,553,789		$	1,175,973	$	2,946,568		$	5,584,570	$	2,991,125	$	2,114,266		$	5,377,494		$	2,167,549	$	—		$	23,911,334
Cost of revenue and operating expenses		931,163			633,375		2,634,086			3,083,727		1,985,060		1,014,007			2,807,405			908,642		—			13,997,465

Operating income (loss)		622,626			542,598		312,482			2,500,843		1,006,064		1,100,259			2,570,089			1,258,907		—			9,913,869
Interest (expense)		(670	)		—		(855	)		102		—		(4,375	)		(7,006	)		—		(1,977,111	)		(1,989,915	)
Other income (expense)		—			—		2,689			—		—		—			10,427			—					(13,116	)
Income (loss) before provision for income taxes and minority interest		621,956			542,598		314,316			2,500,945		1,006,065		1,095,884			2,573,510			1,258,907		(1,977,111	)		7,937,070
Provision for income taxes		231,079			202,894		121,274			850,840		411,282		374,133			613,637			428,752		—			3,233,891
Income (loss) before minority interest		390,877			339,704		193,042			1,650,105		594,783		721,751			1,959,873			830,155		(1,977,111	)		4,703,179
Minority interest in earnings of discontinued operations		—			—		—			—		—		—			770,339			—		—			770,339

Income from discontinued operations		390,877			339,704		193,042			1,650,105		594,783		721,751			1,189,534			830,155		(1,977,111	)		3,932,840
Loss from disposal of discontinued operations, net of tax		—			—		—			—		—		—			—			—		—			—

Total income (loss) from discontinued operations	$	390,877		$	339,704	$	193,042		$	1,650,105	$	594,783	$	721,751		$	1,189,534		$	830,155	$	(1,977,111	)	$	3,932,840

(a)	Adjustments include $587,500 in disposition costs for the six months ended June 30, 2007. Interest was allocated at $2,839,158 and $1,977,111 for the six months and three months ended June 30, 2007 respectively.

Physiom, CPM ASC and PainCare Surgery Centers, Inc. are allocated in the ancillary operating segment. HCCT, ALO, CPM, GPP and TCC are allocated in the Pain Management operating segment. The results of the discontinued operations of HCCT, ALO, GPP, CPM, CPM ASC, TCC, Physion and the PainCare Surgery Centers, Inc, businesses, included in the accompanying consolidated statements of operations for the three months ended June 30, 2006 were as follows:


	2006
	Physiom			TCC			GPP			ALO		HCCT			CPM			CPMASC			PCSI			Adjustments			Total
Net Revenue	$	1,383,723		$	962,897		$	1,518,316		$	479,499	$	691,966		$	2,839,397		$	1,629,615		$	3,244,054		$	—		$	12,749,467
Cost of revenue and operating expenses		421,107			536,166			1,435,699			254,353		459,462			1,544,847			1,018,587			1,499,071			—			7,169,292

Operating income (loss)		962,616			426,731			82,617			225,146		232,504			1,294,550			611,028			1,744,983			—			5,580,175
Interest (expense)		—			—			(415	)		—		—			—			—			(4,571	)		(666,387	)		(671,373	)
Other income (expense)		—			(3,872	)		476			—		(670	)		(33	)		—			1,688			—			(2,411	)
Income (loss) before provision for income taxes and minority interest		962,616			422,859			82,678			225,146		231,834			1,294,517			611,028			1,742,100			(666,387	)		4,906,391
Provision (benefit) for income taxes		328,013			145,304			43,560			94,961		98,210			809,824			(52,775	)		445,068			—			1,912,165
Income (loss) before minority interest		634,603			277,555			39,118			130,185		133,624			484,693			663,803			1,297,032			(666,387	)		2,994,226
Minority interest in earnings of discontinued operations		(118,516	)		—			—			—		—			—			—			514,985			—			396,469

Income from discontinued operations		753,119			277,555			39,118			130,185		133,624			484,693			663,803			782,047			(666,387	)		2,597,757
Loss from disposal of discontinued operations, net of tax		—			—			—			—		—			—			—			—			—			—

Total income (loss) from discontinued operations	$	753,119		$	277,555		$	39,118		$	130,185	$	133,624		$	484,693		$	663,803		$	782,047		$	(666,387	)	$	2,597,757


	June 30, 2007 (unaudited)		December 31, 2006
Assets
Cash	$	226,206	$	1,292,159
Accounts receivable		6,045,560		10,402,272
Deposits and prepaids		378,376		776,364
Deferred taxes		—		96,235

Current assets of discontinued operations		6,650,142		12,567,030

Property and equipment, net		830,862		2,156,871
Goodwill		8,792,320		58,951,126
Other assets		404,473		1,023,634
Non-current deferred tax asset		1,529,561		852,341

Non-current assets of discontinued operations		11,557,216		62,983,972

Total assets of discontinued operations	$	18,207,358	$	75,551,002

Liabilities
Accounts payable and accrued liabilities	$	236,939	$	1,961,848
Current portion of capital lease obligations		—		18,367
Current portion of notes payable		—		62,000
Deferred taxes, current		1,529,561		—

Current liabilities of discontinued operations		1,766,500		2,042,215
Capital lease obligations		—		46,859
Deferred taxes		—		218,109

Long term liabilities of discontinued operations		—		264,968

Total liabilities of discontinued operations	$	1,766,500	$	2,307,183

Minority interest in discontinued operations		2,904,605		2,191,797
Book value of net assets	$	13,536,253	$	71,052,022

The following table shows the components of the loss from sale of Centeno Shultz, Inc. (TCC), net of taxes as of February 28, 2007:


Proceeds	$	(1,419,302	)
Book value of net assets disposed		(1,769,108	)
Cost of disposition		(18,906	)

Loss on sale of discontinued operations		(368,712	)
Income tax benefit, net of valuation allowance of $134,551		—

Loss on sale of discontinued operations, net	$	(368,712	)

On April 30, 2007, the PainCare Holdings Inc. parties and Georgia Pain Physicians, PC, (“GPP”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $125,000. $50,000 is due at closing and the remaining balance is a $75,000 promissory note payable in three consecutive installments of $25,000 a month starting June 1, 2007 and paid in full no later than August 1, 2007. Due to the immaterial nature, interest is not imputed on this note.

The following table shows the components of the loss from sale of Georgia Pain Physicians, PC net of taxes as of April 30, 2007:


Proceeds	$	125,000
Book value of net assets disposed		(658,682	)

Loss on sale of discontinued operations	$	(533,682	)
Income tax benefit, net of valuation allowance of $53,655		—

Loss on sale of discontinued operations, net	$	(533,682	)

On May 21, 2007, the PainCare Holdings Inc. parties and Kenneth Alo, M.D., P.A., (“ALO”) entered into a Settlement Agreement pursuant to which said parties rescinded the Purchase Transaction and terminated agreements among them. To effectuate the rescission of the Purchase Transaction, (i) the PainCare Sub sold, and the Original Practice purchased, substantially all of the assets the PainCare Sub for purchase price of $200,000, due at closing, along with a promissory note in the amount of $200,000 to be repaid with 1290 interest in six consecutive installments of $34,510 beginning on June 15, 2007. As of June 30, 2007, the PainCare, Inc. parties have received $34,510 in cash payments for the sale of the PainCare Sub leaving a remaining balance on the note in the amount of $167,490.

The following table shows the components of the loss from sale of Alo, M.D., P.A., net of taxes as of May 21, 2007:


Proceeds	$	400,000
Book value of net assets disposed		(6,800,169	)

Loss on sale of discontinued operations	$	(6,400,169	)
Income tax benefit permanent difference, not applicable		—

Loss on discontinued operations, net	$	(6,400,169	)

The following table shows the components of the loss from sale of The HealthCare Center of Tampa, net of taxes as of May 22, 2007:


Proceeds	$	570,428
Book value of net assets disposed		(1,412,815	)

Loss on sale of discontinued operations		(842,387	)

Income tax benefit, net of valuation allowance of $124,039		—

Loss on sale of discontinued operations, net	$	(842,387	)

The following table shows the components of the loss from sale of The Center for Pain Management ASC, LLC, net of taxes as of May 21, 2007:


Proceeds	$	7,860,094
Book value of net assets disposed		(12,959,709	)

Loss on sale of discontinued operations		(5,099,615	)
Income tax benefit, net of valuation allowance of $3,920,441		—

Loss on sale of discontinued operations, net	$	(5,099,615	)

The following table shows the components of the loss from sale of The Center for Pain Management, LLC, net of taxes as of May 21, 2007:


Proceeds	$	7,376,739
Book value of net assets disposed		(25,733,820	)

Loss on sale of discontinued operations		(18,357,081	)
Income tax benefit, net of valuation allowance of $5,684,872		—

Loss on sale of discontinued operations, net	$	(18,357,081	)

Liquidity and Capital Resources

General

HBK Notice of Default

CPM Notice of Default

Convertible Debentures

Liquidated damagers on PIPE investments

Contractual Obligations

A summary of our contractual obligations and commercial commitments at June 30, 2007 were as follows:


	Total		Less than 1 Year		One-3 Years		Three-5 Years		5+ Years
Long-term debt	$	22,436,760	$	22,436,760	$	—	$	—	$	—
Convertible debentures		12,839,354		12,839,354		—		—		—
Capital leases		2,595,582		1,196,410		586,225		812,947		—
Operating leases		8,452,424		2,246,196		4,880,713		975,512		350,003
Acquisition consideration		1,645,328		811,996		833,332
Employment agreements		2,100,000		600,000		1,500,000		—		—
Total contractual obligations	$	49,880,492	$	40,071,151	$	7,670,879	$	1,788,459	$	350,003

Critical Accounting Policies

Our discussion and analysis of our results of operations and liquidity and capital resources are based on our consolidated financial statements which have been prepared in accordance with generally accepted accounting principles (“GAAP”) in the United States. In connection with the preparation of our consolidated financial statements, we are required to make assumptions and estimates about future events, and apply judgment that affects the reported amounts of assets, liabilities, revenue, expenses, and the related disclosures. We base our assumptions, estimates and judgments on historical experience, current trends and other factors we believe to be relevant at the time we prepared our consolidated financial statements. On a regular basis, we review the accounting policies, assumptions, estimates and judgments to ensure that our consolidated financial statements are presented fairly and in accordance with GAAP. However, because future events and their effects cannot be determined with certainty, actual results could differ from our assumptions and estimates, and such differences could be material.

Our significant accounting policies are discussed in Note 1, Summary of Significant Accounting Policies, to our consolidated financial statements included in our 2006 Form 10-K and Note 1, Basis of Presentation , to our condensed consolidated financial statements included under Part I, Item 1, Financial Statements (Unaudited), of this report. Of our significant accounting policies, those that we consider to the be most critical to aid in fully understanding and evaluating our reported financial results, as they require management’s most difficult, subjective or complex judgments, resulting from the need to make estimates about the effect of matters that are inherently uncertain, are disclosed in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations , “Critical Accounting Policies,” to our 2006 Form 10-K.

Recent Accounting Pronouncements

For additional information regarding recent accounting pronouncements, please see Note 1, Organization and Basis of Presentation, to our condensed consolidated financial statements included under Part I, Item 1, Financial Statements (Unaudited), of this report.

Unless otherwise required by law, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise after the date of this quarterly report. In light of these risks and uncertainties, the forward-looking events and circumstances discussed in the filing may not occur, and actual results could differ materially from those anticipated or implied in the forward-looking statements.

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Market risk generally represents the risk of loss that may result from the potential change in value of a financial instrument as a result of fluctuations in interest rates and market prices. We do not currently have any trading derivatives nor do we expect to have any in the future. We have established policies and internal processes related to the management of market risks, which we use in the normal course of our business operations.

Interest Rate Risk

We are subject to interest rate risk in that our senior credit facility accrues interest at variable market rates. As of June 30, 2007, we had $23.3 million of variable rate debt outstanding under the senior credit facility. At December 31, 2006, the facility bore interest at the rate of LIBOR plus 7.25% or Prime plus 4.5%. On March 21, 2007 we received notice from the Agent that the default interest rate of LIBOR plus 10.25% (15.57%) was then in effect. A hypothetical 10.55% increase in the interest rate under the facility would decrease our pre-tax earnings and operating cash flows by approximately $382,100. The hypothetical increase is computed by analyzing the historical rate increase subject to LIBOR over the Company’s term of the credit facility.

Intangible Asset Risk

We have a substantial amount of intangible assets. We are required to perform goodwill impairment tests whenever events or circumstances indicate that the carrying value may not be recoverable from estimated future cash flows. As a result of our periodic evaluations, we may determine that the intangible asset values need to be written down to their fair values, which could result in material charges that could be adverse to our operating results and financial position. At December 31, 2006, we performed the impairment tests and determined impairment was needed for both goodwill and the other intangible assets. The total impairment was $33,994,512 for continuing operations and $2,297,013 for discontinued operations. During the six months ended June 30, 2007 the total impairment was $15,076,947 for continuing operations and $48,167,439 for discontinued operations.

ITEM 4.

CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

We maintain “disclosure controls and procedures,” as such term is defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) designed to ensure information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in Securities and Exchange Commission rules and forms, and that such information is accumulated and communicated to our management, including our chief executive officer and chief financial officer, as appropriate, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, we carried out an evaluation, under the supervision and with the participation of our disclosure committee and management, including our chief executive officer and chief financial officer, of the effectiveness of the design and operation of our disclosure controls and procedures pursuant to Exchange Act Rules 13a-15(b) and 15d-15(b). During this evaluation, management considered the impact any material weaknesses and other deficiencies in our internal control over financial reporting might have on our disclosure controls and procedures. In accordance with Section 404 of the Sarbanes-Oxley Act and the rules and regulations promulgated under this section, we were required for our Annual Report on Form 10-K for the year ended December 31, 2006 to evaluate and report on our internal control over financial reporting. In our report contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2006, we reported the following material weaknesses:

•

Inadequate segregation of duties in the field locations

•

Inadequate controls to timely identify, analyze, record, and properly disclose all transactions with related parties

•

Inadequate controls over the authorization, reconciliation and the safeguarding of assets

•

Inadequate controls over operating knowledge or training, adequate backup and security of certain critical financial systems

•

Inadequate controls over the timeliness and accuracy of the monthly close process

•

Inadequate technical expertise with respect to income tax accounting and tax compliance to effectively oversee these areas

•

Inadequate controls to ensure validity, completeness and accuracy of contractual adjustments

•

Inadequate controls over the reconciliation and controls surrounding payroll

•

Inadequate controls related to proper accounting for complex and non-routine transactions

•

Inadequate controls to monitor and analyze retirement plans

Because the material weaknesses identified in connection with the assessment of our internal control over financial reporting as of December 31, 2006 have not yet been remediated, our Chief Executive Officer and our Chief Financial Officer concluded our disclosure controls and procedures were not effective as of June 30, 2007. To address these control weaknesses, the Company performed additional analysis and performed other procedures in order to prepare the unaudited quarterly consolidated financial statements in accordance with generally accepted accounting principles in the United States of America.

The certifications of our Chief Executive Officer and our Chief Financial Officer required in accordance with Section 302 of the Sarbanes-Oxley Act of 2002 are attached as exhibits to this Quarterly Report on Form 10-Q. The disclosures set forth in this Item 4 contain information concerning the evaluation of our disclosure controls and procedures, referred to in paragraph 4 of the certifications. Those certifications should be read in conjunction with this Item 4 for a more complete understanding of the matters covered by the certifications.

Remediation Plans for Material Weaknesses in Internal Control over Financial Reporting

In order to remediate the material weaknesses in internal control over financial reporting and ensure the integrity of our financial reporting processes for the remainder of 2007, we are planning the following enhancements:

Identification and implementation of the proper accounting for complex, non-routine transactions, contractual adjustments, assets and retirement plans.

Additional staffing to allow the controller and assistant controller essential times to oversee the accounting organization as well as other actions to strengthen the operation and effectiveness of our internal controls, accounting issues, and prepares the required disclosures in the notes to the financial statements.

Engage a third party advisor with expertise in identifying, researching and evaluating the appropriateness of complex accounting principles and for evaluating the effects of new accounting pronouncements.

Segregation of duties in the field locations and controls over payroll

Consolidation of disbursements and the payroll process from decentralized field locations into a centralized process at the company’s headquarters.

Timely identify, analyze, record, and properly disclose all transactions with related parties

Consolidation of disbursements and the payroll process from decentralized field locations into a centralized process at the company’s headquarters.

Operating knowledge or training, adequate backup and security of certain critical financial systems

Engage a third party advisor with expertise in information system security to help implement, train and ensure compliance with corporate IT policies and procedures.

Timeliness and accuracy of the monthly close process

Consolidation of disbursements and the payroll process from decentralized field locations into a centralized process at the company’s headquarters.

Accounting for income taxes

Continuing education for income tax accounting and compliance for the controller and assistant controller.

Engage a third party advisor to provide oversight over the income tax accounting and tax compliance as well as other actions to strengthen the income tax accounting function within the organization.

Until these changes are fully implemented, the material weaknesses will continue to exist. Management presently anticipates that the changes necessary to remediate these weaknesses will be in place by the end of the third quarter of 2007.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II – OTHER INFORMATION

ITEM 1.

LEGAL PROCEEDINGS

Class Action

Derivative Action

On April 7, 2006, Kenneth R. Cope filed a derivative complaint against the directors of the Company before the United States District Court for the Middle District of Florida. The complaint is entitled Cope v. Reuter, et al. , Case No. 06-CV-00449-JA-DAB. Mr. Cope alleges that the directors breached their fiduciary duties by failing to supervise and manage the operations of the company, among other claims. (This litigation is referred to as the “Derivative Action.”). In November of 2006, the Company and the plaintiff entered into a Stipulation and Agreement of Compromise, Settlement and Release, filed on November 30, 2006, and conditioned upon court approval. Concurrently with the filing of the foregoing agreement, the parties jointly moved for preliminary court approval, and thereafter, for final approval following notice to the Company’s shareholders. The Stipulation and Agreement was preliminarily approved by the court on January 12, 2007, and finally approved on April 20, 2007, at which time the Derivative Action was dismissed.

Other Matters

Additional disclosure regarding the foregoing litigation and other litigation involving the Company is set forth in the Company’s annual report on Form 10-K for the year ended December 31, 2006.

ITEM 1A.

RISK FACTORS

In addition to the other information set forth in this report, you should carefully consider the factors discussed in Item 1A, Risk Factors, in our 2006 Form 10-K, which could materially affect our business, financial condition, or operating results. The risks described in our 2006 Form 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition, or operating results.

ITEM 2.

UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

The following information sets forth certain information for all securities sold by the Company during the three months ended June 30, 2007 without registration under the Securities Act of 1933, as amended (the “Securities Act”).

Between April 1, 2007 and June 30, 2007 a total of 61,892 common stock shares were issued representing the third of three earnout installments related to the Associated Physicians Group.

Between April 1, 2007 and June 30, 2007 a total of 620,944 common stock shares were issued representing the third of three earnout installments related to the Health Care Center of Tampa.

With respect to the foregoing offers and sale of restricted securities, the Company relied on the provisions of Sections 4(2) and 4(6) of the Securities Act and rules and regulations promulgated thereunder, including, but not limited to Rules 505 and 506 of Regulation D. The offers and sale of the securities was not made by any means of general solicitation, the securities were acquired by the investors without a view towards distribution, and all purchasers represented to the Company that they were sophisticated and experienced in such transactions and investments and able to bear the economic risk of their investment. A legend was placed on the certificates or instruments, as the case may be, they have not been registered under the Securities Act and setting forth the restrictions on their transfer and sale. Each investor also signed a written agreement that the securities would not be sold without registration under the Securities Act or pursuant to an applicable exemption from such registration.

ITEM 3.

DEFAULTS UPON SENIOR SECURITIES

HBK Notice of Default

CPM Notice of Default

On March 15, 2007, we received a notice of breach and default (the “CPM Notice”) from The Center for Pain Management, LLC (“CPM”) with respect to that certain Asset Acquisition Agreement dated December 1, 2004 (the “APA”) entered into by the Company, PainCare Acquisition Company XV, Inc. (the “Subsidiary”), CPM, and the owners of CPM (the “Members”). The CPM Notice provides that unless the alleged events of default set forth in the CPM Notice are cured by the Company, (i) certain non-competition and non-solicitation provisions binding the Members will cease as of April 24, 2007, and (ii) CPM and the Members will have, as of April 12, 2007, certain rights under that certain Stock Pledge Agreement dated December 1, 2004 (the “Pledge Agreement”) entered into by the Company and the Members, including, but not limited to, the right to foreclose on the issued and outstanding shares of stock of the Subsidiary. Since receipt of the CPM Notice we have been actively engaged in negotiations with CPM in an effort to resolve the disputes. We have, as a result of the foregoing negotiations, reached an agreement in principal providing for our sale of CPM and the related surgery center operations to those individuals from whom we originally purchased the operations. The completion of the transactions remains subject to the negotiation and execution of definitive transaction documents. On May 21, 2007 the original purchase transaction was rescinded and the debt was forgiven.

Convertible Debentures

ITEM 4.

SUBMISSION OF MATTER TO A VOTE OF SECURITIES HOLDERS

No matters require disclosure

ITEM 5.

OTHER INFORMATION

No matters require disclosure

ITEM 6.

EXHIBITS


No.		Description
3.01		Articles of Incorporation (1)

3.02		By Laws (1)

3.03		Amendment to Bylaws (2)

3.04		Amendment to Articles of Incorporation (3)

4.1		2000 Stock Option Plan of PainCare, Inc. (1)

4.2		2001 Stock Option Plan of PainCare, Inc. (1)

10.1		Mutual Settlement Agreement and General Release effective as of May 15, 2007 between PainCare, Inc., PainCare Acquisition Company IX , Inc., Kenneth M. Alo, M.D., NCCK Children’s Trust, Alpha Two, LLC, Alpha Three, FLP, Alo Nongrantor Trust, Delta KMA One, LLC, Delta KMA Two, FLP and Kenneth Alo, P.A.(4)

10.2		Settlement Agreement as of May 16, 2007 by and among PainCare Holdings, Inc. and Saqib Khan M.D. (4)

10.3		Agreement by and among Secured Creditors effective May 21, 2007 by and among PainCare Holdings, Inc., PainCare Acquisition Company XV, Inc. and PainCare Surgery Centers III, Inc., The Center for Pain Management, LLC, The Center for Pain Management ASC, LLC and HBK Investment, L.P.(5)

31.1		Certification of Chief Executive Officer of PainCare Holdings, Inc. pursuant to Rule 13a - 14(a)/15d-14(a) of the Securities Exchange Act of 1934.

31.2		Certification of Chief Financial and Accounting Officer of PainCare Holdings, Inc. pursuant to Rule 13a - 14(a)/15d-14(a) of the Securities Exchange Act of 1934.

32.1		Certifications of Chief Executive Officer and Chief Financial and Accounting Officer of PainCare Holdings, Inc. pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

(1)	Previously filed with the SEC with the Company’s Form S-4 on January 4, 2002

(2)	Previously filed with the SEC with the Company’s Form 8-K on July 12, 2005

(3)	Previously filed with the SEC with the Company’s Form 8-K on August 11, 2005

(4)	Previously filed with the SEC with the Company’s Form 8-K on May 29, 2007

(5)	Previously filed with the SEC with the Company’s Form 8-K on June 7, 2007

SIGNATURES

In accordance with Section 13 or 15(d) of the Exchange Act, the Registrant caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date: August 28, 2007		PainCare Holdings, Inc.

		/s/ Randy A. Lubinsky
		Randy A. Lubinsky
		Chief Executive Officer

Date: August 28, 2007		/s/ Mark Szporka
		Mark Szporka
		Chief Financial & Accounting Officer

EXHIBIT 31.1

CERTIFICATION PURSUANT TO 13A-14 OF THE

SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PainCare Holdings, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2007 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Randy A. Lubinsky, Chief Executive Officer of the Company, hereby certify that:

1. I have reviewed this quarterly report on Form 10Q of the company;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: August 28, 2007		/s/ Randy A. Lubinsky
		Randy A. Lubinsky
		Chief Executive Officer

EXHIBIT 31.2

CERTIFICATION PURSUANT TO 13A-14 OF THE SECURITIES

EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PainCare Holdings, Inc. (the “Company”) on Form 10-Q for the period ending June 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Mark Szporka, Chief Financial and Accounting Officer of the Company, hereby certify that:

1. I have reviewed this quarterly report on Form 10Q of the company;

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: August 28, 2007		/s/ Mark Szporka
		Mark Szporka
		Chief Financial and Accounting Officer of the Company

EXHIBIT 32.1

CERTIFICATIONS OF

CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER OF

PAINCARE HOLDINGS, INC.

PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of PainCare Holdings, Inc. (the “Company”) for the period ending June 30, 2007, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), Randy Lubinsky, as Chief Executive Officer of the Company, and Mark Szporka, as Chief Financial and Accounting Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of and for the period covered by the Report.

/s/ Randy Lubinsky

Randy Lubinsky, Chief Executive Officer

Date: August 28, 2007

/s/ Mark Szporka

Mark Szporka, Chief Financial and

Accounting Officer

Date: August 28, 2007